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Background: The term frailty is used to describe older persons who are at 
increased risk of adverse health outcomes. Various measures have been 
investigated but Fried’s criteria are used most often. However, there is still a 
lack of consensus on the definition of frailty. Simpler measures based on postal 
questionnaires have also been investigated in the assessment of frailty. 
Different measures may only partly identify the same persons as frail, and in 
addition the predicted outcomes may vary depending on the measure used.  
Older persons in general and older frail persons have benefited from 
exercise interventions. Some studies have also revealed that persons with 
dementia may benefit from exercise intervention. However, there is a lack of 
evidence on whether or not the stage of frailty affects the outcomes of exercise 
intervention among persons with dementia.  
Among older persons in general, known risk factors of falls are, for 
example, a history of falls, muscle weakness, gait deficit, arthritis, depression, 
polypharmacy, psychotropic medication and older age. Fewer studies have 
concerned risk factors of falls among persons with dementia. No study has 
been carried out to investigate possible interactions between exercise, fall-
related drugs and falls among people with dementia.  
Aims: This study aimed to investigate how various frailty measures 
overlap, whether or not they identify the same persons as frail, and to explore 
if the outcomes are similar irrespective of the used measure. This study also 
investigated whether or not the frailty status of community-dwelling persons 
with Alzheimer Disease (AD) affects the outcomes of exercise intervention. In 
addition, this study explored risk and protective factors associated with falls 
among persons with AD and whether there are interactions between exercise 
intervention, fall-related drugs, and falls in this population.  
Subjects and methods: The subjects in Study I were the participants of 
the Helsinki Businessmen Study, which is a long-term observational study of 
men born in 1919–1934. These men were investigated by analyzing their 
responses in postal questionnaires in 2000 and 2005. A total of 480 men were 
included in the study, and their mean age was 73 years at the start of follow-
up. Two phenotype-based measures, the Helsinki Businessmen Study (HBS) 
measure and the modified Women’s Health Initiative Observational Study 
(WHI-OS) measure, and the Frailty Index (FI), consisting of 20 items, were 
used to identify frailty through postal questionnaires. The measures were 
investigated in regard to how they overlapped in identifying robust, prefrail 
and frail individuals and how they predicted falls, health-related quality of life 
(HRQoL, 15D instrument), weight change and mortality during a five year 
follow-up period.  
The subjects in Studies II, III and IV were the participants of the Finnish 
Alzheimer disease exercise trial (FINALEX), which was an exercise 
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intervention study among home-dwelling persons with AD. The mean age of 
the participants (N=194) was 78 years and 39% were women. The participants 
in intervention groups underwent group-based or home-based exercise for one 
hour twice weekly for 12 months (N=129), and the control group had normal 
care (N=65). In the FINALEX study, falls were recorded in fall diaries by AD 
persons’ spousal caregivers during the one-year follow-up period. In Study II, 
both the combined intervention group and the control group were subdivided 
into prefrail (0–1 criteria) and advanced frailty (2–5 criteria) according to 
modified Fried phenotypic criteria. The number of falls per person-years and 
changes in the Functional Independence Measure (FIM) served as outcome 
measures.  
In Study III, all participants were investigated together to reveal fall risk 
factors in connection with physical functioning, diseases and drugs. Study IV 
investigated possible interactions between exercise and fall-related drugs by 
comparing the incidence rate ratios (IRRs) of falls among non-users and users 
of various drugs in intervention and control groups.  
Results: Both the HBS measure and the WHI-OS measure identified 7.3% 
of the participants of the Helsinki Businessmen Study as frail, but only partly 
were they the same individuals. The FI measure identified 17.9% of the 
participants as frail. Altogether, 21.3% of the participants were classified as 
frail by at least one measure. All measures (HBS, WHI-OS, FI) predicted a 
significantly higher number of fallers, lower HRQoL, and higher mortality 
among frail participants than among prefrail and not frail participants. There 
were no differences as regards weight changes between the frailty stages or 
frailty groups.  
In the FINALEX study, in the prefrail groups the average rate of falls was 
significantly lower in the intervention group than in the control group (1.14 
falls/person per year [95% confidence interval (CI): 0.90 to 1.43] and 1.82 
falls/person per year [95% CI: 1.40 to 2.32], respectively; IRR 0.63 [95% CI: 
0.45 to 0.89]; P=0.008 adjusted for sex, age and comorbidities). In the 
advanced frailty groups also, the participants in the intervention group had a 
significantly lower rate of falls than those in the control group (2.15 
falls/person per year [95% CI: 1.76 to 2.59] and 5.32 falls/person per year 
[95% CI: 4.36 to 6.44], respectively; IRR 0.43 [95% CI: 0.33 to 0.57]; P<0.001 
adjusted for sex, age and comorbidities). Both intervention groups also 
deteriorated significantly more slowly than their respective control groups 
according to changes in FIM scores.  
Better physical functioning and robustness protects against falls among 
persons with AD. Diseases such as chronic obstructive pulmonary disease, 
diabetes and arthritis, as well as drugs such as opioids, psychotropics, drugs 
with anticholinergic properties, and polypharmacy were associated with an 
increased risk of falls. Use of antihypertensives was associated with a reduced 
risk of falls among those undertaking exercise, but there was an increased risk 




Conclusions: The HBS measure, the WHI-OS measure and the FI 
measure identified frail participants, but there was only a partial overlap. The 
FI identified more persons as frail. All three measures predicted increased falls 
and mortality and reduced HRQoL among the frail participants.  
People with AD may benefit from exercise intervention irrespective of their 
frailty status in respect of falls and physical functioning. Better physical 
functioning and robustness protect against falls. Several diseases and drugs 
were risk factors of falls. Exercise favorably interacted with antihypertensives 




Tutkimuksen tausta: Termiä gerastenia käytetään kuvaamaan hauraita 
ikääntyneitä ihmisiä, joilla on suurentunut riski haitallisille 
päätetapahtumille. Erilaisia mittareita on tutkittu, mutta useimmiten on 
käytetty Friedin kriteerejä. Kuitenkaan yhteisymmärrystä gerastenian 
määritelmästä ei ole vielä saatu aikaan. Myös yksinkertaisempia kyselyihin 
perustuvia mittareita on tutkittu gerastenian arvioimiseksi. Eri mittarit 
saattavat tunnistaa gerastenisiksi vain osittain samoja henkilöitä, ja myös 
ennustetut päätetapahtumat saattavat vaihdella käytetystä mittarista 
riippuen.  
Iäkkäät ihmiset yleensä ja gerasteniset iäkkäät ihmiset ovat hyötyneet 
useissa tutkimuksissa liikuntainterventiosta. Muutamissa tutkimuksissa on 
nähty, että myös ihmiset, joilla on muistisairaus, voivat hyötyä 
liikuntainterventiosta. Kuitenkaan ei ole näyttöä, vaikuttaako gerastenian aste 
liikuntainterventiosta hyötymiseen muistisairailla henkilöillä.  
Tiedettyjä ikääntyneiden ihmisten yleisiä riskitekijöitä kaatumisille ovat 
esimerkiksi kaatumishistoria, lihasheikkous, kävelyvaikeus, nivelrikko, 
masennus, monilääkitys, psyykelääkkeiden käyttö ja korkeampi ikä. Selvästi 
vähemmän on tutkimuksia kaatumisten riskitekijöistä muistisairailla 
henkilöillä. Aikaisempia tutkimuksia mahdollisista interaktioista liikunnan ja 
kaatumisiin liittyvien lääkkeiden välillä suhteessa kaatumisiin ei ole 
muistisairailla potilailla.  
Tutkimuksen tavoitteet: Tämä tutkimus tutki, kuinka eri gerastenian 
mittarit limittyvät toistensa suhteen, tunnistavatko ne samoja henkilöitä 
gerastenisiksi ja ovatko päätetapahtumat samanlaisia riippumatta käytetystä 
mittarista.  
Tämä tutkimus myös tutki, vaikuttiko gerastenian aste 
liikuntainterventiosta hyötymiseen kotona asuvilla Alzheimerin tautia 
sairastavilla henkilöillä.  
Lisäksi tämä tutkimus selvitti kaatumisiin liittyviä suojaavia ja riskiä 
lisääviä tekijöitä Alzheimerin tautia sairastavilla henkilöillä, ja onko 
liikuntainterventiolla ja kaatumisiin liittyvillä lääkkeillä interaktioita 
kaatumisten suhteen tässä joukossa.  
Aineisto ja menetelmät: Osatutkimuksen I aineistona ovat osallistujat 
Helsinki Johtajat –tutkimuksessa, joka on pitkäaikainen havaintotutkimus 
vuosina 1919-1934 syntyneistä miehistä. Näitä miehiä tutkittiin heidän 
vuosina 2000 ja 2005 postitse antamiensa kyselyvastaustensa perusteella. 
Yhteensä 480 miestä sisältyi tutkimukseen ja heidän keski-ikänsä oli 73 vuotta 
seurannan alussa. Kaksi ilmiasuun perustuvaa mittaria, Helsinki Johtajat –
tutkimuksen mittari HBS (eng. Helsinki Businessmen Study) ja muokattu 
Women’s Health Initiative Observational Study (WHI-OS), sekä gerastenian 
indeksimittari (eng. Frailty Index, FI), joka koostui 20 kohdasta, rakennettiin 
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tunnistamaan gerasteniaa kirjekyselyn perusteella. Mittareita tutkittiin, 
kuinka ne menivät päällekkäin ei-gerastenisten, esi-gerastenisten ja 
gerastenisten henkilöiden tunnistamisessa ja kuinka ne ennustivat 
kaatumisia, terveyteen liittyvää elämänlaatua, painonmuutosta ja 
kuolleisuutta viiden vuoden seurannassa.  
Osatutkimuksien II, III ja IV aineistona ovat osallistujat FINALEX-
tutkimuksessa, joka oli liikuntainterventiotutkimus kotona asuvilla 
Alzheimerin tautia sairastavilla henkilöillä (eng. Finnish Alzheimer disease 
exercise trial). Osallistujien (yhteensä 194 henkilöä) keski-ikä oli 78 vuotta ja 
39 % heistä oli naisia. Osallistujat liikuntainterventioryhmissä (yhteensä 129 
henkilöä) saivat joko ryhmäliikuntainterventiota tai kotiliikuntainterventiota 
yhden tunnin kerrallaan kahdesti viikossa 12 kuukauden ajan, ja 
kontrolliryhmä (yhteensä 65 henkilöä) sai normaalia kunnallista hoitoa. 
FINALEX-tutkimuksessa Alzheimerin tautia sairastavien osallistujien 
puolisot seurasivat kaatumisia kaatumispäiväkirjojen avulla 12 kuukauden 
seurannan ajan. Osatutkimuksessa II sekä yhdistettu 
liikuntainterventioryhmä että kontrolliryhmä jaettiin esi-gerastenisiin (0-1 
kriteeriä) ja enemmän gerastenisiin (2-5 kriteeriä) muokattujen Friedin 
kriteerien mukaisesti. Kaatumiset henkilövuotta kohden ja muutokset FIM-
toimintakykymittarissa (Functional Independence Measure) toimivat 
tulosmuuttujina.  
Osatutkimuksessa III kaikkia osallistujia tutkittiin yhdessä kaatumisiin 
liittyvien riskitekijöiden, kuten fyysisen toimintakyvyn, sairauksien ja 
käytettyjen lääkkeiden, suhteen. Osatutkimuksessa IV tutkittiin mahdollisia 
interaktioita liikuntaintervention ja kaatumisiin liittyvien lääkkeiden välillä 
vertaamalla kaatumisten ilmaantuvuustiheyksien suhteita (eng. incidence rate 
ratio, IRR) eri lääkkeiden käyttäjien ja ei-käyttäjien kesken 
liikuntainterventioryhmässä ja kontrolliryhmässä.  
Tulokset: Sekä HBS-mittari että WHI-OS-mittari tunnistivat 7,3 % 
Helsinki Johtajat –tutkimuksen osallistujista gerastenisiksi, mutta näistä vain 
osa oli samoja henkilöitä. FI mittari tunnisti 17,9 % gerastenisiksi. 
Kaikenkaikkiaan 21,3 % osallistujista tunnistettiin gerastenisiksi vähintään 
yhden mittarin mukaan. Kaikki mittarit (HBS, WHI-OS, FI) ennustivat 
merkitsevästi enemmän kaatujia, huonompaa elämänlaatua ja suurempaa 
kuolleisuutta gerastenisille, kuin esi-gerastenisille tai ei-gerastenisille 
henkilöille. Painon muutoksen suhteen ei ollut eroja eri gerastenian asteiden 
tai mittareiden välillä.  
FINALEX-tutkimuksessa esi-gerastenisissa ryhmissä keskimääräinen 
kaatumisten määrä oli merkitsevästi pienempi liikuntainterventioryhmässä 
kuin kontrolliryhmässä (1,14 kaatumista henkilövuotta kohden [95 %:n 
luottamusväli (eng. 95 % confidence interval, CI): 0,90-1,43] ja 1,82 
kaatumista henkilövuotta kohden [95 % CI: 1,40-2,32]; IRR 0,63 [95 % CI: 
0,45-0,89]; P=0,008 sukupuoli, ikä ja liitännäissairaudet huomioitu). Myös 
enemmän gerastenisissa ryhmissä keskimääräinen kaatumisten määrä oli 
merkitsevästi pienempi liikuntainterventioryhmässä kuin kontrolliryhmässä 
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(2,15 kaatumista henkilövuotta kohden [95 % CI: 1,76-2,59] ja 5,32 kaatumista 
henkilövuotta kohden [95 % CI: 4,36-6,44]; IRR 0,43 [95 % CI: 0,33-0,57]; 
P<0,001 sukupuoli, ikä ja liitännäissairaudet huomioitu). Kummankin 
liikuntainterventioryhmän fyysinen toimintakyky myös heikkeni 
merkitsevästi hitaammin kuin heidän vastaavien kontrolliryhmiensä FIM-
toimintakykymittarin muutoksien perusteella.  
Parempi fyysinen toimintakyky ja ei-gerastenisuus suojaavat kaatumisilta 
Alzheimerin tautia sairastavilla potilailla. Sairaudet, kuten 
keuhkoahtaumatauti, diabetes ja nivelrikko, sekä lääkkeet, kuten opioidit, 
psyykelääkkeet, lääkkeet, joilla on antikolinergisia ominaisuuksia, ja 
monilääkitys, liittyivät kohenneeseen kaatumisriskiin. Verenpainelääkkeiden 
käyttö liittyi alentuneeseen kaatumisriskiin liikuntainterventiota saaneilla, 
mutta kohonneeseen kaatumisriskiin kontrolliryhmällä. Liikuntainterventio 
vähensi kaatumisriskiä myös psyykelääkkeiden käyttäjillä.  
Johtopäätökset: HBS-mittari, WHI-OS-mittari ja FI-mittari tunnistivat 
vain osittain samat henkilöt gerastenisiksi. FI tunnisti gerastenisiksi 
enemmän kuin muut. Kaikki kolme mittaria ennustivat suurempaa 
kaatumismäärää ja kuolleisuutta sekä huonompaa terveyteen liittyvää 
elämänlaatua gerastenisille osallistujille.  
Alzheimerin tautia sairastavat henkilöt voivat hyötyä liikuntainterventiosta 
suhteessa kaatumisiin ja fyysiseen toimintakykyyn riippumatta gerastenian 
asteesta. Parempi fyysinen toimintakyky ja ei-gerastenisuus suojaavat 
kaatumisilta. Tietyt sairaudet ja lääkkeet olivat kaatumisten riskitekijöitä. 
Liikuntainterventiolla oli suosiollinen interaktio verenpainelääkkeiden ja 
psyykelääkkeiden kanssa suhteessa kaatumisriskiin.  
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1 INTRODUCTION  
The term frailty is used to describe older persons whose health status has 
deteriorated without being a direct consequence of disease (Fulop et al. 2010). 
Frail persons often have disabilities (Fulop et al. 2010) and they are prone to 
various complications (Rockwood & Mitnitski 2007, Fulop et al. 2010). 
Although frail persons have existed throughout history the term frailty is 
relatively new (Strandberg et al. 2011). It was first used in the 1970s (Abellan 
van Kan et al. 2008a) and the definition is still developing (Strandberg et al. 
2011). There is still no consensus of opinion as regards the official definition 
of frailty today (Fulop et al. 2010, Azzopardi et al. 2016).  
Frailty is not a synonym for disability nor for comorbidity (Fried et al. 
2004, Clegg et al. 2013). Nowadays the definition of frailty does not include 
the deterioration of functionality and a person does not have to have any 
disease to be frail (Fulop et al. 2010). However, often these are present at the 
same time (Rockwood et al. 2004). Frailty has a poor prognosis (Rockwood & 
Mitnitski 2007). It leads to disabilities, complications and an increased risk of 
mortality (Rockwood et al. 1994, Fried et al. 2001, Bortz 2002, Fried et al. 
2004, Morley et al. 2006, Rockwood & Mitnitski 2007, Rolland et al. 2008, 
Fulop et al. 2010). Prevention and treatment of frailty have been intensively 
investigated in recent years (Clegg et al. 2013). So far the strongest evidence 
as regards preventing and treating frailty is for exercise (Strandberg et al. 
2011).  
The global prevalence of dementia is approximately 5–7%, Alzheimer 
disease (AD) being one of the most common types (Prince et al. 2013). It was 
estimated that 35.6 million people had dementia in 2010 and the number is 
expected to almost double every 20 years (Prince et al. 2013). Dementia and 
cognitive impairment are major risk factors of falls, as approximately 60% of 
persons with these conditions fall annually (Tinetti et al. 1988, van Dijk et al. 
1993). Dementia and cognitive impairment also affect overall physical 
functioning, as they increase the risk of frailty, and vice versa (Robertson et al. 
2013). The prevalence rates of both dementia and frailty increase with age, 
they are especially common among women, they have mutual etiological 
factors such as smoking, obesity, a low level of physical activity, and 
depression, and both of them also have poor prognosis as regards 
institutionalization and mortality (Sampson 2012). It has been suggested that 
cognition and frailty affect each other and also general health status with aging 
(Robertson et al. 2013). The prevalence of dementia has been found to be 
higher among frail persons than among robust people (Han et al. 2014, 
Kulmala et al. 2014).  
A meta-analysis showed that physical exercise training may reduce the 
number of falls among persons with dementia or cognitive impairment (Chan 
et al. 2015). However, only a few exercise studies have concerned community-
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dwelling persons with dementia (Pitkala et al. 2010). So far the most 
promising form of intervention seems to be intensive, long-term and diverse 
exercise training (Pitkala et al. 2010). Community-dwelling persons with AD 
have benefitted from intense and long-term exercise training in respect of 
physical functioning and falls without increasing the total cost of health and 
social services (Pitkala et al. 2013).  
Exercise has been shown to be an effective way to prevent falls among 
cognitively intact people in several studies. However, there are only a few trials 
concerning the effects of exercise in dementia. Furthermore, although people 
with dementia are known to be prone to falls, little is known about why and 
how they fall and how their frailty and cognitive status interact with falls.  
The present studies were carried out to investigate how various frailty 
measures identify older persons’ frailty stages and how they predict health 
outcomes such as falls, quality of life (QoL) and mortality, and whether the 
stage of frailty has an effect on the benefits of exercise intervention among 
people with AD. These studies also concern the circumstances and associated 
factors of falls and whether there are interactions between exercise 
intervention and fall-related drugs (FRDs).  
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2 REVIEW OF THE LITERATURE 
 
2.1 FRAILTY  
The term frailty was first mentioned in the literature in the 1970s when it was 
used as a synonym for institutionalization (Abellan van Kan et al. 2008a). In 
the 1980s it was used to describe disabilities (Abellan van Kan et al. 2008a). 
Thereafter it has been developing and in the 1990s and 2000s a consensus of 
opinion was reached that it is an independent concept (Fried et al. 2001, Fried 
et al. 2004, Morley et al. 2006).  
Decreased body reserves (Bergman et al. 2007, Strandberg & Pitkala 2007), 
decreased ability to counteract stressors (Bergman et al. 2007, Strandberg & 
Pitkala 2007, Clegg et al. 2013), and an increased risk of poor prognosis 
(Rockwood et al. 1994, Fried et al. 2001, Bortz 2002, Fried et al. 2004, Morley 
et al. 2006, Rockwood & Mitnitski 2007, Rolland et al. 2008, Fulop et al. 2010, 
Clegg et al. 2013) have been suggested to be characteristics of frailty. Frailty 
has been distinguished from disabilities and comorbidities (Fried et al. 2001, 
Fisher 2005), although it often appears with them at the same time (Fried et 
al. 2001). Figure 1 shows the relationship of frailty according to Fried criteria 
with comorbidities, and disabilities in the Cardiovascular Health Study: of frail 
participants, nearly half (46.2%) had comorbidities, 5.7% had disabilities, 
21.5% had both comorbidities and disabilities, and about one quarter (26.6%) 
did not have comorbidities or disabilities (Fried et al. 2001).  
  
Figure 1. Venn diagram showing proportions of frail participants in respect to disability and 
comorbidity. Figure modified from the Cardiovascular Health Study (Fried et al. 2001).  
 
19 
However, we still lack an official definition of frailty (Fulop et al. 2010, 
Azzopardi et al. 2016). Populations are getting older and defining frailty is 
even more important than before (Rockwood 2005). For research a simple and 
clear definition would be practical as it would facilitate setting the research 
questions and also comparison of different studies (Fisher 2005). It is also 
important to define frailty to be able to recognize frail persons for early 
intervention and for prevention and treatment (Strandberg & Pitkala 2007).  
2.1.1 DIAGNOSIS AND CLASSIFICATION  
There have been many propositions for definitions of frailty. Two of them are 
widely used: the Fried criteria presenting the phenotype of frailty (Fried et al. 
2001), and the Frailty Index (FI) presenting deficit accumulation criteria 
(Mitnitski et al. 2001).  
2.1.1.1 Phenotype of frailty 
Of the proposed definitions, the Fried criteria (Fried et al. 2001) and its 
modifications are most often used (Strandberg & Pitkala 2007). The Fried 
criteria stands for phenotype of frailty and are based on mobility parameters 
and weight change (Fried et al. 2001). The five Fried criteria are: unintentional 
weight loss, weakness, exhaustion, slow gait speed, and a low level of physical 
activity (Fried et al. 2001). A person is considered to be frail if at least three 
criteria are present, and prefrail if one or two criteria are present. If none of 
the criteria are present the person is considered to be robust (Fried et al. 2001). 
Table 1 summarizes the Fried criteria.  
Table 1. The Fried criteria for the phenotype of frailty (Fried et al. 2001).  
Criterion (if present, 1 pt) Definition 
Unintentional weight loss >10 lbs (4.5 kg) in preceding year 
Weakness Lowest quintile in grip strength (by body mass index, 
gender) 
Exhaustion Self-reported exhaustion 
Slow gait speed Lowest quintile in walking speed (by height, gender) 
Low physical activity Lowest quintile in Kcals/week (males: <383 Kcals/week, 
females: <270 Kcals/week) 
Frailty: 3–5 criteria present: frail; 1–2 criteria present: prefrail; 
0 criteria present: robust 
 
The Fried criteria have been widely used since 2001 (Strandberg et al. 2011) 
and they have predicted important outcomes such as disabilities and mortality 
(Fried et al. 2001, Bandeen-Roche et al. 2006). However, Fried criteria have 
also been criticized because they take into account only physical 
characteristics, ignoring biological, psychological and social aspects (Fisher 




2.1.1.2 Frailty Index (FI)  
The Fried criteria are thought to be usable but there has been intense 
discussion on adding geriatric problems and cognitive capacity to the criteria 
of frailty (Rockwood et al. 2004, Rockwood 2005). If that were to be the case 
important geriatric aspects would be more comprehensively considered 
(Rockwood 2005). Frailty status is presumably different between two persons 
whose physical characteristics are similar but other features such as cognitive 
function are different (Rockwood 2005).  
The FI is widely used and it takes into consideration features other than 
physical characteristics (Mitnitski et al. 2001, Fisher 2005). The FI is 
quantitative and is composed of various items (Mitnitski et al. 2001, Fisher 
2005), usually 30–70 items (Song et al. 2010). These are various aspects of 
physical, cognitive, psychological and social dimensions (Mitnitski et al. 2001, 
Fisher 2005) such as motivation, communication, motion, balance, urinary 
and intestinal function, activities of daily living (ADL), nutrition, diseases, and 
social contacts (Mitnitski et al. 2001, Abellan van Kan et al. 2008a). The FI is 
calculated simply by dividing the number of deficits by the number of 
measured features (Mitnitski et al. 2001, Mitnitski et al. 2002). Thus, the FI 
gives a value between 0–1 in which 1 is for a person with all the measured 
deficits and 0 for a person with no deficits (Mitnitski et al. 2001, Mitnitski et 
al. 2002). The FI is a continuous measure of frailty (Mitnitski et al. 2001) but 
researchers have often used cut-off points of ≥0.25 to identify frail people and 
0.08–0.249 to identify prefrail persons, whereas those scoring <0.08 are 
considered to be robust (Rockwood et al. 2004, Rockwood et al. 2007, Song et 
al. 2010). For example, persons with nine or more deficits in 36 items are 
considered to be frail, those with 3–8 deficits as prefrail, and those with 0–2 
as robust.  
The FI is significantly associated with mortality (Rockwood et al. 2007). It 
also enables evaluation of different study groups (Clegg et al. 2013). However, 
it is cumbersome to use in clinical work, and, thus, is not suitable in primary 
healthcare (Strandberg et al. 2011). It has been suggested that the Fried 
criteria and the FI are too different to be alternatives (Cesari et al. 2014). 
Instead, they could be used to complement and support each other (Cesari et 
al. 2014).  
2.1.1.3 Other frailty measures  
The phenotypic Fried criteria have been modified according to the study 
population and relevant data (Sirola et al. 2011). For example, a RAND-36 
health survey questionnaire was used as a basis to construct the Helsinki 
Businessmen Study (HBS) frailty measure (Sirola et al. 2011). The HBS frailty 
measure is based on four criteria: weight loss (over 5% from midlife to 
senescence, or body mass index (BMI) <21 kg/m²), physical weakness (self-
reported difficulty in carrying a grocery bag), exhaustion (according to the 
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RAND-36 Vitality Scale from), and physical inactivity (not exercising regularly 
on a weekly basis) (Sirola et al. 2011). Those with 3–4 criteria present are 
considered frail, those with 1–2 criteria as prefrail, and those with no criteria 
as robust (Sirola et al. 2011).  
The Women’s Health Initiative Observational Study (WHI-OS) measure 
(Woods et al. 2005) is another measure with modified Fried criteria. It has the 
same criteria for unintentional weight loss and physical inactivity as in the 
HBS (Woods et al. 2005). Exhaustion is defined according to the RAND-36 
Vitality Scale: “Did you feel worn out? Did you feel tired? Did you have a lot of 
energy? Did you feel full of pep?”, with a score of <55 indicating the criterion 
is present. Slowness/weakness is evaluated as a two-point measure and the 
other three are single-point measures. Slowness/weakness is present if the 
score is <75 in the RAND-36 Physical Function Scale (Woods et al. 2005). 
Persons with 3–5 points are considered frail, those with 1–2 points as prefrail, 
and those with no points as robust (Woods et al. 2005).  
The Study of Osteoporotic Fractures (SOF) frailty index is composed of 
three items: weight loss of ≥5% over three years, inability to rise from a chair 
five times without using arms, and reduced energy level (answer “no” to the 
question “Do you feel full of energy?” (Ensrud et al. 2008). Each of the three 
items is scored one point when present (Ensrud et al. 2008). According to the 
sum of points a person is classified as robust (0 points), prefrail (1 point), or 
frail (2 or 3 points) (Ensrud et al. 2008). The SOF frailty index predicted the 
risks of falls, fractures, disability, and death equally well as the more complex 
Fried’s criteria (Ensrud et al. 2008).  
The FRAIL scale is a simple 5-item questionnaire used to evaluate frailty 
(Abellan van Kan et al. 2008a, Abellan van Kan et al. 2008b). Each item is 
evaluated either as present (1 point) or not present (0 points) (Morley et al. 
2012). Fatigue is evaluated as present with answers “All of the time” or “Most 
of the time” to the question “How much of the time during the past four weeks 
did you feel tired?” Resistance is evaluated as present with the answer “Yes” to 
the question “By yourself and not using aids, do you have any difficulty walking 
up ten steps without resting?” Ambulation is evaluated as present with the 
answer “Yes” to the question “By yourself and not using aids, do you have any 
difficulty walking several hundred yards?” Illnesses are evaluated as present 
when a person has 5 to 11 diseases of the 11 asked about (cancer [other than a 
minor skin cancer], chronic lung disease, hypertension, heart attack, 
congestive heart failure, angina, stroke, diabetes, asthma, kidney disease, and 
arthritis). Loss of weight is evaluated as present when over 5% in one year 
(Morley et al. 2012). The FRAIL scale is suitable for screening frail persons 
and it has been validated (Morley et al. 2012).  
The Edmonton Frail Scale (EFS) assesses nine domains of frailty: general 
health status, cognition, social support, mood, continence, functional 
independence, functional performance, medication usage, and nutrition 
(Rolfson et al. 2006). These are evaluated by way of 11 items, of which six score 
0, 1 or 2 points, and five score 0 or 1 point (Rolfson et al. 2006). Thus, the total 
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score is from 0 to 17, of which scores of ≤5 points refer to no frailty, scores of 
6–11 refer to apparently vulnerable, and scores of 12–17 refer to severe frailty 
(Perna et al. 2017). The Edmonton Frail Scale is a valid, reliable and feasible 
frailty measure (Rolfson et al. 2006, Perna et al. 2017).  
Winograd’s frail scale classifies persons to three categories: independent 
people are those who are independent in all aspects of ADL, with short-term 
acute illness; frail people are those who meet any one of the assessed criteria 
(cerebrovascular accident, chronic and disabling illness, confusion, 
dependence in ADL, depression, falls, impaired mobility, incontinence, 
malnutrition, polypharmacy, pressure sores, prolonged bed-rest, restraints, 
sensory impairment, socioeconomic/family problems); severely impaired 
people are those who have severe dementia and ADL-dependence or have 
terminal illness (Winograd et al. 1991). Winograd’s frail scale is inexpensive 
and effective and can easily be introduced into clinical settings (Winograd et 
al. 1991).  
Even simpler measures have also been used to identify frail individuals 
(Morley et al. 2002). These include slow gait speed (if it takes over 10 seconds 
to walk three meters back and forth), “Timed Up and Go” test with a glass of 
water (if it takes over 4.5 seconds longer to walk three meters back and forth 
with a glass than without it), and abnormal balance on one foot (Morley et al. 
2002). The advantage of these measures is that they are simple and cheap.  
Gait speed over a 4-meter distance could be the most suitable test in clinical 
work to screen for frailty as it is not only cheap and simple but also reliable 
(Abellan van Kan et al. 2008a, Abellan van Kan et al. 2009). A gait speed of 
≤0.6 m/s predicts failing in a 400-meter walking test (Rolland et al. 2004), 
passing of which is considered to be crucial to maintain independence and a 
high quality of life in the community (Pahor et al. 2006, Pahor et al. 2014).  
Fried criteria have also been modified so as to be able to screen for frailty 
status in the population via questionnaire investigations (Woods et al. 2005, 
Etman et al. 2012).  
2.1.2 EPIDEMIOLOGY OF FRAILTY 
A systematic review revealed that the prevalence of frailty varies widely, from 
4.0% to 59.1% among community-dwelling persons (Collard et al. 2012). 
Taking into account all the studies in the review, 10.7% of the persons were 
frail and 41.6% were prefrail (Collard et al. 2012). In one study of community-
dwelling participants the prevalence was over ten times higher among 90-
year-old (56.3%) than among 65-year-old (4.8%) persons (Brody et al. 1997).  
The lack of consensus on an official definition of frailty is one reason for 
different prevalence rates in various studies (Bortz 2002, Fried et al. 2004, 
Strandberg et al. 2011, Collard et al. 2012). Studies involving use of the FI 
usually present a higher prevalence of frailty than those involving the use of 
phenotype-based measures (Fried et al. 2001, Song et al. 2010, Jurschik et al. 
2012, Malmstrom et al. 2014, Kojima et al. 2015, Widagdo et al. 2015). The 
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prevalence is also affected by the characteristics of the study population (Fried 
et al. 2001, Strandberg et al. 2011). The prevalence of frailty increases with age 
(Fried et al. 2001, Song et al. 2010, Strandberg et al. 2011, Collard et al. 2012). 
Females are more often frail than males (Fried et al. 2001, Song et al. 2010, 
Collard et al. 2012). Lower socioeconomic status, diseases, disabilities and 
institutionalization increase the prevalence of frailty (Fried et al. 2001, 
Strandberg et al. 2011). Both poor psychological and financial well-being have 
also been associated with frailty (Hubbard et al. 2014).  
Frailty and dementia share some risk factors such as smoking, obesity, low-
level physical activity, and depression, and it has been suggested that they 
increase each other’s prevalence (Sampson 2012). Many studies have shown a 
higher prevalence of dementia among frail persons than among prefrail or 
robust persons (Robertson et al. 2013). Both cognitive impairment and 
dementia are common among frail persons (Avila-Funes et al. 2009, Jurschik 
et al. 2012). A systematic review and meta-analysis revealed frailty to be a 
significant predictor of dementia among community-dwelling older people 
(Kojima et al. 2016a). One study on frailty in AD patients revealed 22% to be 
robust, 28% to be prefrail and 50% to be frail (Bilotta et al. 2012). The frail 
persons also had more severe degrees of cognitive impairment (Bilotta et al. 
2012).  
Table 2 presents the prevalence of frailty in various studies with different 



















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































2.1.3 BIOLOGICAL BASIS OF FRAILTY  
Both inflammatory and coagulative alterations have been suggested to play a 
part in the pathogenesis of frailty (Kanapuru & Ershler 2009). Aging is 
associated with changes in the amounts of cytokines, resulting in a decrease of 
body reserves (Fulop et al. 2010). In developing frailty there are similar but 
stronger changes resulting in the clinical frailty syndrome (Fulop et al. 2010). 
Increased interleukin 6 (IL-6) concentrations have shown the strongest 
association with frailty (Fulop et al. 2010), and other associated cytokines are 
C-reactive protein (CRP), tumor necrosis factor α (TNF-α), and ligand 10 of 
the CXC chemokine family (CXCL10) (Walston et al. 2006, Clegg et al. 2013).  
It has been argued that most human organs have an approximately 70% 
margin, meaning that 30% function of the total capacity is enough to support 
normal function (Bortz 2002). The pathogenesis of frailty includes decreases 
of reserves in multiple body organs, for example in the digestive system, 
muscles, bones, circulatory system, the brain, and the immune system, and 
depressed hormone function (Fried et al. 2004, Abellan van Kan et al. 2008a). 
Various frailty-related diseases and symptoms include anorexia, weight loss, 
sarcopenia, osteopenia, atherosclerosis, congenital impairment, exhaustion, 
hormone deprivation and reduced inflammatory reactions (Strandberg et al. 
2011). In frailty, some body reserves are decreased close to the 30% margin, 
after which it may be difficult to compensate for even a small disturbance in 
body or environment (Fried et al. 2001, Fried & Walston 2003, Fried et al. 
2004).  
Figure 2 shows possible relationships between molecular, physiological 
and functional factors related to frailty (Walston et al. 2006, Fulop et al. 2010).  
 
  
Figure 2. Hypothesis of mechanisms in the development of frailty (IGF-1: insulin-like growth 
factor 1; IL-6: interleukin 6).  
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2.1.4 RISK FACTORS AND ASSOCIATED FACTORS OF FRAILTY  
The development of frailty is associated with genetic, biological, physical, 
psychological, social, and environmental domains (Rockwood & Mitnitski 
2007). Four entities have been thought to be the most important: genetic 
properties, aging, lifestyles, and outcomes of diseases and traumas (Bortz 
2002, Fried et al. 2004).  
Female gender provides an example of genetic influence (Fried et al. 2001). 
Frailty prevalence is higher among women than among men, and a major 
factor is that muscle mass and power are lower and they decrease faster among 
women (Fried et al. 2001). Menopause hastens the development of frailty 
(Nedergaard et al. 2013). Some genetic disorders may also contribute to the 
development of frailty, but they occur in a minor proportion of the total frail 
population (Bortz 2002).  
The amount of muscle tissue decreases with age (Hughes et al. 2002). A 
decrease in nutritional intake along with reduced exercise results in decreased 
muscle mass (Morley 2001). Aging also brings possible accumulation of 
metabolic byproducts, stiffness of muscle fascia and changes in DNA, causing 
muscle weakness (Bortz 2002). However, aging is probably not itself the 
reason for loss of muscles, as not all persons lose muscles in aging (Fiatarone 
et al. 1990). A widely accepted functional aspect of aging is a situation in which 
the physiological reserves cannot cope with any disturbances although they 
function normally in a steady state (Fulop et al. 2010). When reserves have 
decreased to the marginal 30% level along with aging and the body faces a 
factor disturbing the steady state it may be argued that aging strongly 
contributes to the development of frailty (Fulop et al. 2010). However, aging 
and frailty are two different entities, as not all people become frail even when 
they are very old (Strandberg et al. 2011). Aging does not cause frailty but is a 
predisposing factor (Strandberg et al. 2011).  
Lifestyles are thought to be the most important factor in the development 
of frailty (Bergman et al. 2007). Lifestyles at an advanced age have an effect 
but they are also important in middle age and even in youth (Savela et al. 
2013).  
Exercise during the whole course of life has shown benefits in preventing 
frailty (Savela et al. 2013). The participants of the Helsinki Businessmen Study 
were divided into three groups based on their exercise activity in their middle 
age: low, moderate, and high (Savela et al. 2013). High-level physical activity 
in leisure time in middle age predicted a significantly lower prevalence of 
frailty or prefrailty 26 years later at an advanced age (Savela et al. 2013). A 
sedentary life style leads to decreased muscle power and frailty (Bortz 2002). 
This is supported by many studies demonstrating an association between 
insufficient exercise and muscle degradation in later decades of life (Bortz 
2002).  
As regards nutrition the problem is getting enough energy and especially 
enough protein in advanced age, whereas in youth and middle age the problem 
is getting too much energy (Morley 2007). Too much nutritional energy intake 
 
28 
causes obesity, type 2 diabetes mellitus, and cardiovascular diseases 
(Strandberg et al. 2013a, Strandberg et al. 2013b, Stenholm et al. 2014). These 
conditions are also associated with insufficient exercise (Savela et al. 2013) 
and smoking (Strandberg et al. 2008). Smoking shortens life and also quality-
adjusted life years (QALY) and is associated with frailty (Strandberg et al. 
2008, Hubbard et al. 2009). The development of frailty may thus begin in early 
middle age and obesity is one etiologic factor (Stenholm et al. 2014). It has 
been reported that both those remaining overweight and those reducing 
weight from obesity to a normal weight level over 26 years were more frail and 
had more disabilities and poorer prognoses compared with those staying at a 
normal weight (Strandberg et al. 2013b). The risk of frailty is also increased by 
alcohol intake, metabolic syndrome, and certain diseases such as diabetes, 
atherosclerosis, and infections (Strandberg et al. 2011).  
The above-mentioned chronic diseases themselves cause chronic 
inflammation and also predispose individuals to acute diseases (Fulop et al. 
2010). The effects of diseases and traumas are at least partly explained by 
reduced exercise levels (Toth & Poehlman 2000). This reduces muscle mass, 
which in turn accelerates the decrease of body reserves (Clegg et al. 2013). 
With lack of reserves the body is more vulnerable to disturbances (Fulop et al. 
2010). Inflammation is associated with frailty (Ferrucci et al. 2002, Roubenoff 
2003) because it disturbs the functions of various organ systems via cytokine 
action (Fulop et al. 2010). The term secondary frailty is used when diseases 
have had a major impact in its development and the term primary frailty is 
used in the absence of such contributing diseases (Strandberg & Pitkala 2007).  
2.1.5 OUTCOMES OF FRAILTY  
Frailty has a poor prognosis (Rockwood & Mitnitski 2007). It leads to 
disabilities, complications and an increased risk of death (Rockwood et al. 
1994, Fried et al. 2001, Bortz 2002, Fried et al. 2004, Morley et al. 2006, 
Rockwood & Mitnitski 2007, Rolland et al. 2008, Fulop et al. 2010). Prefrailty 
also predisposes persons to diseases and disabilities, exacerbating their 
consequences and making it more difficult to recover from acute illnesses 
(Fried et al. 2001). According to a systematic review and meta-analysis both 
prefrailty and frailty are significant predictors of fractures among community-
dwelling older people (Kojima 2016).  
Frailty more often worsens than evolves towards a better condition (Fried 
et al. 2001). In the Cardiovascular Health Study (CHS) mortality was higher 
among frail (18%) than among prefrail (7%) or robust (3%) persons after three 
years of follow-up as well as after seven years of follow-up (43%, 23%, 12%, 
respectively) (Fried et al. 2001). Frailty remained as an independent risk factor 
of falls, institutionalization, and increased rates of disabilities and mortality 
after adjusting for socioeconomic level, health status, clinical and subclinical 
diseases, depression symptoms and present disabilities (Fried et al. 2001). The 
prefrail group showed more than a 2.5-fold increased risk of developing frailty 
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during 3–4 years of follow-up compared with the robust group (Fried et al. 
2001). In the Helsinki Businessmen Study the mortality rate during seven 
years of follow-up showed similar figures: 39% in the frail group, 19% in the 
prefrail group, and 8% in the robust group (Sirola et al. 2011). Both frailty and 
prefrailty predicted mortality after adjusting for [OK?] age, BMI, smoking, 
frailty phenotype criteria, the Charlson comorbidity index and mobility 
disabilities (Sirola et al. 2011).  
2.1.6 PREVENTION AND MANAGEMENT OF FRAILTY  
Reducing the prevalence and severity of frailty probably benefits both 
individuals and society (Clegg et al. 2013). The prevention of frailty should 
begin early, focusing on lifestyles (Strandberg et al. 2011), as they are thought 
to be a major factor in developing frailty (Bergman et al. 2007) and because 
lifestyles in early adulthood and even in youth may contribute to its 
development (Savela et al. 2013).  
Lifelong exercise training and physical activity prevent frailty (Savela et al. 
2013). As several studies have revealed muscle weakness to be associated with 
increased mortality and to contribute to frailty development, exercise training 
provides a simple means of prevention and rehabilitation (Bortz 2002). Over-
nutrition and overweight should be avoided in youth and middle age, whereas 
at a more advanced age sufficient energy intake (especially protein intake) 
prevents frailty (Morley 2007). Efficient treatment of diseases and traumas 
decreases the risk of frailty (Strandberg et al. 2011). Early mobilization and 
adequate nutrition in acute illnesses is important, especially among older 
people (Strandberg et al. 2011). Probable preventive factors against frailty 
include healthy nutrition, nonsmoking, moderate alcohol consumption and 
taking care of overall health status (Bergman et al. 2007). Vaccines developed 
against both acute and chronic infections may decrease chronic inflammation 
and frailty (Fulop et al. 2010).  
Several different forms of intervention have been studied to reduce frailty 
(Clegg et al. 2013). Intervention measures have consisted of exercise, nutrition 
and pharmacological intervention, as well as different combinations of these 
(Strandberg et al. 2011, Clegg et al. 2013). Exercise intervention has shown the 
most evidence of effectiveness (Walston et al. 2006, Strandberg et al. 2011). In 
a systematic review it was suggested that frail older adults seem to benefit from 
exercise interventions (de Labra et al. 2015). A meta-analysis revealed exercise 
training to benefit frail older people in respect of enhancing gait speed, balance 
and ADL (Chou et al. 2012). Another systematic review on exercise in frailty 
revealed that only three out of 47 studies had defined frailty according to a 
valid definition (Theou et al. 2011). There is strong evidence that exercise 
enhances functionality of the heart, respiratory system and muscles, and 
physical activity and functional ability (Theou et al. 2011). There is also 
moderate evidence that exercise is of benefit in psychological and biochemical 
domains, as well as decreasing adverse outcomes (Theou et al. 2011). A 
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diverse, long-term (more than five months) program of exercise training, 30–
45 minutes three times a week has benefited the most (Theou et al. 2011). A 
diverse mixture of strength, endurance and balance training seems best to 
reduce falls and enhance gait and physical function in physically frail older 
people (Cadore et al. 2013b). A 12-week circuit-training program has reduced 
the fear of falling and enhanced health status among physically frail older 
people (Gine-Garriga et al. 2013). A study on exercise, dietary 
supplementation and both of these showed only exercise to benefit frail older 
people (Fiatarone et al. 1994). Exercise interventions may benefit prefrail 
more than frail persons (Faber et al. 2006).  
Nutritional interventions may enhance nutritional status and prevent 
weight loss in frailty, but there is scarce evidence (Clegg et al. 2013). Protein 
and energy supplements enhance weight gain but do not affect the ability to 
function among older people (Milne et al. 2009). Nutritional interventions 
based on energy supplementation have not been efficient in frailty (Walston et 
al. 2006). However, a daily protein supplement for 12 weeks reduced the 
worsening of functional decline among frail older people of relatively low 
socioeconomic status (Kim & Lee 2013).  
Only a few pharmacological means have been investigated in the 
management of frailty (Clegg et al. 2013). For example, erythropoietin, 
angiotensin-converting enzyme inhibitors (ACE inhibitors) and statins have 
shown benefits that could possibly be used to prevent and manage frailty, but 
there is no clear evidence of benefits in functional ability (Walston et al. 2006). 
In clinical trials anabolic steroids such as testosterone and 
dehydroepiandrosterone (DHEA) increased muscle mass but they did not 
increase muscle functionality without exercise training (Walston et al. 2006). 
Side effects limit their use (Walston et al. 2006). However, pharmacological 
agents in the prevention and management of frailty remain an important topic 
in future studies (Clegg et al. 2013).  
An intervention study on exercise and nutrition combined led to a decrease 
in frailty stage (from frail to prefrail/robust or from prefrail to robust) in three 
months, compared with a control group (Chan et al. 2012). However, this 
change was no longer evident after six and twelve months of follow-up (Chan 
et al. 2012). Another intervention study combining exercise with nutritional 
and psychological care showed that the intervention group had a significantly 
higher gait speed and activity level than a control group (Fairhall et al. 2012).  
It seems that interventions benefit the frailest less than prefrail persons 
(Beswick et al. 2008). Advancing memory diseases are known to predispose 
people to frailty (Sampson 2012). However, there is lack of studies concerning 
how to slow down the progression to frailty among persons with dementia 
(Sampson 2012).  
Intervention studies are presented in Table 5 (below, in Section 2.3.1, 
Exercise interventions in frailty).  
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2.2 FALLS  
Falls and injuries increase with age (Campbell et al. 1990, Rubenstein & 
Josephson 2002). Risk factors of falls have been studied extensively in older 
populations in general, but there are fewer studies on risk factors of falls 
among people with dementia (Allan et al. 2009, Salva et al. 2012, Meuleners 
et al. 2016). Persons with cognitive impairment and dementia are at major risk 
of falls (Tinetti et al. 1988, van Dijk et al. 1993).  
2.2.1 DEFINITION OF A FALL  
A fall has been defined in various ways (Hauer et al. 2006). A widely used 
definition proposed in 1987 described a fall as “unintentionally coming to the 
ground or some lower level and other than as a consequence of sustaining a 
violent blow, loss of consciousness, sudden onset of paralysis as in stroke or 
an epileptic seizure” (Kellogg 1987). Later, a simpler definition was suggested, 
being ‘‘an unexpected event in which the participants come to rest on the 
ground, floor, or lower level’’ (Lamb et al. 2005). A systematic review by the 
Prevention of Falls Network Europe group revealed that only half of 
randomized controlled fall-prevention trials had defined a fall, hence 
impeding comparison between different studies (Hauer et al. 2006). On the 
other hand, an answer to a simple question “Did you fall?” has been suggested 
to fulfill clinical and epidemiological purposes with adequate accuracy 
(Dickens et al. 2006). A comprehensive, non-exclusive and simple fall 
definition to be reliably understood by lay people documenting their falls is 
recommended (Hauer et al. 2006).  
2.2.2 EPIDEMIOLOGY OF FALLS 
Approximately one of three community-dwelling persons aged over 65 years 
falls every year (Tinetti et al. 1988, Rubenstein & Josephson 2002). The 
incidence of falls as well as the severity of complications rise after the age of 
60 years (Campbell et al. 1990, Rubenstein & Josephson 2002, Milat et al. 
2011). The incidence is higher among nursing-home residents than among 
those living in the community (Becker et al. 2003). Women fall more than men 
(Deandrea et al. 2010). The incidence of falls varies according to the type of 
population, e.g. persons with Parkinson disease fall more often (Deandrea et 
al. 2010).  
Frailty is a major risk factor of falls (Samper-Ternent et al. 2012). Several 
studies have shown that frail persons fall more than prefrail and robust 
persons (Runzer-Colmenares et al. 2014, Zaslavsky et al. 2016). The 
proportions of fallers have usually varied from 20% to 80% among frail 
persons (Ensrud et al. 2009, Runzer-Colmenares et al. 2014). Frailty also 
predisposes people to recurrent falls (Bandeen-Roche et al. 2015).  
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Cognitive impairment and dementia are major risk factors of falls, as 
approximately 60% of older persons with these disorders fall annually (Tinetti 
et al. 1988, van Dijk et al. 1993). Fewer fallers have also been reported, as a 
Japanese study among AD participants revealed 42% (Horikawa et al. 2005) 
and a Spanish study among dementia participants revealed 36% (Salva et al. 
2012) to fall during one-year of follow-up. In contrast, a UK study among 
dementia participants revealed 66% to fall during one-year of follow-up (Allan 
et al. 2009). The type of dementia affects the number of fallers (Allan et al. 
2009). During one-year follow-up the percentages of fallers were 47% for 
those with AD, 47% for those with vascular dementia, 77% for those with 
dementia with Lewy bodies and 90% for those with Parkinson’s disease with 
dementia (Allan et al. 2009).  
Table 3 presents the incidence of falls in various studies among 











































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































2.2.3 RISK FACTORS AND ASSOCIATED FACTORS OF FALLS  
Risk factors of falls have been extensively investigated in older persons in the 
general population. Well-known risk factors are, for example, a history of falls, 
gait deficits, muscle weakness, disability, visual deficit, arthritis, depression, 
older age, polypharmacy, psychotropic medication, and environmental 
hazards (Tinetti et al. 1988, Campbell et al. 1999, Leipzig et al. 1999, AGS 2001, 
Stalenhoef et al. 2002, AGS 2011).  
There are many risk factors of falls in various domains such as 
sociodemographic factors, medical factors, psychological factors, medication-
related factors, and mobility and sensory factors (Deandrea et al. 2010). Risk 
factors can also be classified as intrinsic factors (e.g. balance disorder, poor 
grip strength, functional and cognitive impairment), extrinsic factors (e.g. 
polypharmacy) and environmental factors (e.g. lack of bathroom safety 
equipment, poor lightning) (AGS 2001).  
Several drug classes and polypharmacy expose older people to the risk of 
falls (AGS 2011) and the use of psychotropic drugs is especially associated with 
falls among older people (Hartikainen et al. 2007, Woolcott et al. 2009). 
Furthermore, drugs with anticholinergic properties (DAPs) are associated 
with an increased frequency of falls (Cardwell et al. 2015, Mayer et al. 2017), 
and antihypertensive drugs have also been associated with an increased risk 
of falls (Hartikainen et al. 2007, Woolcott et al. 2009) and hip fractures 
(Corrao et al. 2015). A systematic review of 74 prospective studies revealed the 
strongest risk associations to be a history of falls (Odds Ratio [OR] = 3.5 for 
recurrent fallers; OR = 2.8 for all fallers), gait problems (OR = 2.2; 2.1), 
walking-aid use OR = 3.1; 2.2), vertigo (OR = 2.3; 1.8), Parkinson’s disease 
(OR = 2.8; 2.7), and antiepileptic drug use (OR = 2.7; 1.9) (Deandrea et al. 
2010). Other moderately associated factors were age, female gender, living 
alone, physical activity limitation, physical disability, instrumental disability, 
cognition impairment, depression, history of stroke, urinary incontinence, 
rheumatic disease, hypotension, diabetes, comorbidity, self-perceived poor 
health status, pain, fear of falling, increase in number of types of medication, 
use of sedatives, use of antihypertensives, vision impairment, and hearing 
impairment (Deandrea et al. 2010).  
Frailty itself increases the risk of falls (Ensrud et al. 2007, Kojima et al. 
2015). Frail persons have shown similarities with community-dwelling older 
persons in the general population in respect of risk factors of falls. For 
example, older age, certain diseases such as cardiovascular diseases and 
depression, and malnutrition have been shown to increase the risk of falls 
among frail persons (Ng et al. 2014).  
Cognitive impairment and dementia are themselves major risk factors of 
falls, leading to approximately 60% of older people with these disorders falling 
annually (Tinetti et al. 1988, van Dijk et al. 1993). There are fewer studies on 
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fall-risk factors among persons with dementia, but a history of falls, older age, 
female gender and disability have been associated with increased risk (Allan 
et al. 2009, Salva et al. 2012, Meuleners et al. 2016). Furthermore, 
symptomatic orthostatic hypotension and symptoms of depression have been 
shown to increase the risk of falls, whereas higher levels of physical activity 
appeared to be protective against falls (Allan et al. 2009). More severe 
cognitive decline has been associated with an increased risk of falls (Gleason 
et al. 2009, Ohman et al. 2016). The use of psychotropic drugs has also been 
associated with an increase in the risk of falls among persons with dementia 
(Horikawa et al. 2005, Kudo et al. 2009).  
2.2.4 OUTCOMES OF FALLS  
The number of falls and adverse outcomes as results of a fall increase with age 
(Campbell et al. 1990, Rubenstein & Josephson 2002). Falls lead to substantial 
rates of mortality and morbidity and they are major contributors to immobility 
and premature nursing home placement (AGS 2001, Rubenstein 2006). 
Women are more likely to be injured as a consequence of falls than men 
(Duckham et al. 2013). One in four fallers faces serious injury, and 
approximately 6% have fractures such as a hip fracture and its possible adverse 
consequences (Tinetti et al. 1988). Minor injuries are more common and may 
be present in two-thirds of fallers (Milat et al. 2011). In the same study 20% of 
fallers required a hospital visit, half of them requiring hospital admission 
(Milat et al. 2011). Falls also result in major costs to society (Scuffham et al. 
2003). These costs increase with age and the two highest costs have been 
reported to be from inpatient admissions (49%) and long-term care (41%) 
(Scuffham et al. 2003).  
2.2.5 PREVENTION OF FALLS  
Effective fall prevention has the potential to reduce emergency department 
visits, serious fall-related injuries, hospitalizations, nursing-home 
placements, and functional decline among older community residents (Sattin 
1992). Reducing fall risk among older individuals is an important public-
health objective (Sattin 1992).  
A wide body of evidence supports a multifactorial or multicomponent 
approach to interventions designed to prevent falls in older persons (Chang et 
al. 2004, Weatherall 2004). Much evidence supports the fact that exercise 
interventions benefit older people in reducing fall risk (Campbell et al. 1999, 
Chang et al. 2004, Gillespie et al. 2012, Guirguis-Blake et al. 2018), and an 
exercise component should be included in all multifactorial interventions 
(AGS 2011). However, multifactorial interventions may offer only small net 
benefits compared with interventions consisting of only exercise (Grossman et 
al. 2018). In most positive trials exercise intervention has lasted at least 12 
weeks (AGS 2011).  
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Possible medication reduction benefits older people in respect of fall 
prevention (AGS 2011). In particular, reduction of psychotropic medication 
has been found to reduce the fall rate (Campbell et al. 1999, Leipzig et al. 1999). 
Vitamin D supplementation has beneficial effects in fall prevention (Bischoff-
Ferrari et al. 2009). Management of home hazards as a single form of 
intervention has shown mixed results (AGS 2011), but is of benefit in reducing 
falls when combined with exercise intervention (Day et al. 2002).  
Falls have also been investigated in connection with frailty (Faber et al. 
2006). Various studies have shown mixed results, as one study showed no 
benefits from exercise intervention (Latham et al. 2003) whereas another 
revealed that an exercise intervention group improved in respect of physical 
functioning and falls (Cadore et al. 2013a). In one study exercise intervention 
reduced the risk of becoming a faller among prefrail participants but increased 
the risk of becoming a faller among frail participants (Faber et al. 2006).  
Although people with dementia are at an increased risk of falls, there has 
been a scarcity of studies investigating prevention of their falls (AGS 2011). 
Just recently, the results of a meta-analysis including seven studies suggested 
that exercise has the potential to prevent falls among people with known 
cognitive impairment (Chan et al. 2015). In a small study of persons with a 
mean Mini-Mental State Examination (MMSE) score of 16.3 the intervention 
group improved in walking, mobility, flexibility and static balance compared 
with the control group (Toulotte et al. 2003). Another study showed 
improvement in a multicomponent exercise intervention group, with a slower 
decline in ADL score and higher gait speed among persons with AD and a 
mean MMSE score of 8.8 (Rolland et al. 2007). There are also studies that have 
revealed no reduction in falls via exercise intervention among persons with 
dementia (Wesson et al. 2013). To my knowledge, there are no studies 
prospectively exploring the characteristics and consequences of falls among 
persons with dementia.  
Table 4 presents fall prevention trials among community-dwelling persons, 













































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































2.3 EXERCISE INTERVENTIONS AMONG OLDER 
PEOPLE 
Lack of exercise is often a major cause of chronic diseases (Booth et al. 2012), 
and exercise interventions have been used to prevent and treat various 
diseases and conditions (Pedersen & Saltin 2015). The diversity of exercise 
interventions in respect of their duration, intensity, and training methods is 
overwhelming (Gillespie et al. 2012). The interventions have often lasted from 
three to 12 months, and the weekly training times have also varied (Gillespie 
et al. 2012). Some studies have concerned only one specific exercise training 
method such as endurance, strength, tai chi, or balance training, whereas 
others have involved different combinations of methods (Chin A Paw et al. 
2008, Theou et al. 2011, Chou et al. 2012, Gillespie et al. 2012).  
2.3.1 EXERCISE INTERVENTIONS IN FRAILTY  
Exercise has been investigated among frail persons (Chin A Paw et al. 2008, 
Theou et al. 2011, Chou et al. 2012). Of different interventions, exercise has 
shown the most benefit for frail persons by improving their balance, gait speed 
and functioning (Chin A Paw et al. 2008, Theou et al. 2011, Chou et al. 2012). 
Various exercise methods have been investigated (Chou et al. 2012). Intensive, 
long-term and diverse exercise interventions are of most benefit (Theou et al. 
2011). Diverse endurance, strength, and balance training seems most effective 
in reducing the number of falls and in enhancing gait and physical ability to 
function among physically frail older persons (Cadore et al. 2013b). 
Multicomponent interventions including exercise and nutrition have also 
shown benefits in frailty in respect of physical functioning (Chan et al. 2012, 
Kim et al. 2015). However, there was no statistically significant additive effect 
of nutritional supplementation with exercise (Kim et al. 2015).  
Some researchers have suggested that prefrail persons may benefit more 
from exercise intervention than frail persons (Faber et al. 2006). However, 
another study showed that frail participants benefited the most from physical 
activity intervention (Cesari et al. 2015). Other researchers have argued that 
physical activity intervention could even reduce the stage of frailty (Cameron 
et al. 2013, Cesari et al. 2015).  




































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































2.3.2 EXERCISE INTERVENTIONS TO REDUCE FALLS  
Exercise interventions have been widely studied in fall prevention and their 
diversity is high (Gillespie et al. 2012). Some studies have concerned a single 
method such as tai chi (Lomas-Vega et al. 2017) whereas others have involved 
various methods in different combinations (Toulotte et al. 2003). There are 
also studies on combinations of exercise and other methods (Gillespie et al. 
2012). Exercise interventions have included personal training (Suttanon et al. 
2013) and group training (Faber et al. 2006), and the intensity has varied 
(Gillespie et al. 2012).  
The most effective exercise interventions in reducing falls have been those 
combining different exercise methods (Gillespie et al. 2012). The 
characteristics of participants also affect the outcomes of exercise 
interventions (Faber et al. 2006). For example, a moderate-intensity exercise 
program had positive effects on falling in prefrail persons but not in frail 
persons (Faber et al. 2006). Exercise interventions to prevent falls are also 
presented above (Section 2.2.5 Prevention of falls and Table 4 in the same 
section).  
2.3.3 EXERCISE INTERVENTIONS IN DEMENTIA  
A meta-analysis revealed that physical exercise training has the potential to 
reduce the number of falls among persons with dementia or cognitive 
impairment (Chan et al. 2015). A few exercise studies among persons with 
dementia have been performed among community-dwelling people (Pitkala et 
al. 2010). The Finnish Alzheimer disease exercise trial (FINALEX) showed 
that intensive and long-term exercise training benefits the physical 
functioning of persons with AD and it also reduced the number of falls without 
increasing the costs of health and social services and without causing serious 
adverse effects (Pitkala et al. 2013). Exercise intervention has benefits for 
persons with mild or advanced AD (Ohman et al. 2016). Recent systematic 
reviews and meta-analyses have revealed that physical exercise may 
significantly prevent falls even among older persons with dementia (Burton et 
al. 2015) or cognitive impairment (Chan et al. 2015). Exercise may also 
improve ADL (Lam et al. 2018). (See also Table 4 in Section 2.2.5, Prevention 






2.4 SUMMARY OF THE LITERATURE 
There is no international consensus on the definition of frailty (Fulop et al. 
2010, Azzopardi et al. 2016), and its prevalence varies according to the various 
frailty measures (Fried et al. 2001, Song et al. 2010, Jurschik et al. 2012, 
Malmstrom et al. 2014, Kojima et al. 2015, Widagdo et al. 2015). However, 
there is a scarcity of studies on comparison of various frailty measures in a 
single population. Frailty indicates a poor prognosis irrespective of the 
measure used (Woo et al. 2012). Postal questionnaire-based frailty measures 
have provided a simple way to investigate frailty (Sirola et al. 2011).  
Dementia and frailty have mutual risk factors (Sampson 2012) and the 
syndromes often overlap (Robertson et al. 2013). Both persons with frailty or 
with dementia are known to benefit from exercise interventions (Chan et al. 
2015, de Labra et al. 2015). However, it is not known whether the stage of 
frailty affects the benefits of exercise intervention in respect of physical 
functioning among persons with dementia.  
Factors behind falls have been widely studied in the general population 
(AGS 2011). A number of risk factors of falls have been identified, such as a 
history of falls, poor physical functioning, FRDs, and certain diseases (Tinetti 
et al. 1988, Campbell et al. 1999, Leipzig et al. 1999, AGS 2001, Stalenhoef et 
al. 2002, AGS 2011). However, there are fewer studies on risk factors and 
especially on circumstances of falls among persons with dementia (AGS 2011).  
It is known FRDs such as psychotropics, DAPs, and antihypertensives 
increase fall risk in the general older population (Hartikainen et al. 2007, 
Woolcott et al. 2009, Cardwell et al. 2015, Mayer et al. 2017). Exercise has the 
potential to reduce fall risk among both older people in general (Gillespie et al. 
2012) as well as among persons with cognitive impairment (Chan et al. 2015). 
To my knowledge, there have been no studies on possible interactions between 
FRDs and exercise interventions.  
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3 AIMS OF THE STUDY  
These studies concern the prognostic significance of frailty measures and they 
explore exercise effects and their interaction with frailty and fall-related drugs 
among people with dementia.  
Specific aims were as follows:  
1. To explore the overlapping of three different frailty measures (HBS, 
modified WHI-OS, FI) in identifying frail individuals among older men 
(Study I)  
2. To explore how different frailty stages according to three frailty 
measures are associated with falls, weight change, QoL, and mortality 
during a five-year follow-up period (Study I)  
3. To explore how the severity of a frailty stage affects the benefits of 
exercise intervention among people with AD in respect of physical 
functioning and falls (Study II)  
4. To explore features of falls among people with AD (Study III)  
5. To identify possible risk factors of falls among people with AD (Study 
III)  
6. To explore possible interactions between exercise intervention and fall-
related drugs on fall risk among people with AD (Study IV)  
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4 METHODS  
4.1 PARTICIPANTS  
4.1.1 PARTICIPANTS IN THE HELSINKI BUSINESSMEN STUDY  
The Finnish Institute of Occupational Health organized health check-ups in 
the 1960s and 1970s to diminish cardiovascular risk among Finnish upper-
social-class businessmen. The participants (N=3490) were all men who had 
been born in 1919–1934 and had worked as executives or businessmen. They 
received health education and their risk factors were evaluated by means of 
laboratory and clinical examinations and questionnaires in 1964–1973. 
Of the men showing an interest in participating in a five-year prevention 
trial (starting in 1974) 1604 were clinically healthy but had a high risk of 
cardiovascular disease (CVD). The rest (N=1886) were sick, dead, refused, did 
not respond to the postal questionnaire or had no risk factors. Those healthy 
men at a high risk of CVD were randomized into intervention (N=612) and 
control (N=610) groups. A low-risk control group (N=593) was formed of 
those not having risk factors for CVD. The formed groups participated in a 5-
year multifactorial prevention trial in 1974–1980. Examinations ten years 
post-trial revealed no benefit in terms of coronary heart disease or mortality. 
Later, the emphasis shifted from the prevention of CVD to geriatric medicine. 
Follow-up has been conducted by means of postal questionnaires since 2000.  
In 2000, a postal questionnaire was sent to survivors of the Helsinki 
Businessmen Study cohort (N=1390) and the majority (N=996, 72%) 
responded. In 2005, a postal questionnaire was sent to a random subcohort 
(N=996). Of these men, 742 responded and 480 had all the needed 
information for analyses available. The year 2000 questionnaire data was used 
as baseline data and all participants that had all information available 
concerning frailty measures and follow-up data (until 2005) were included 
(N=480). Those with missing items and those not included in the subcohort 
(N=516) did not differ from those responding to frailty measures as regards 
age, comorbidities, or baseline distribution of frailty measures (HBS, modified 














































4.1.2 PARTICIPANTS IN THE FINALEX STUDY  
In 2008, the AD drug reimbursement register of the Social Insurance 
Institution of Finland was used to identify persons with AD living with a 
spouse in Helsinki, Espoo or Vantaa (N=1264). They were mailed a letter 
offering the possibility to participate in an exercise trial. Of those sending back 
a prepaid response letter and expressing interest in participating (N=497), 
study nurses managed to contact 390 persons by telephone. Of these, 84 
declined participation and 96 did not fulfil the inclusion criteria.  
The inclusion criteria were investigated by study nurses by telephone and 
were as follows:  
 
- Finnish-speaking  
- living with a spouse at home  
- living in Helsinki, Espoo or Vantaa  
- age ≥65 years, retired  
- no diagnosed terminal disease or severe hemiplegia  
- ability to walk independently with or without a mobility aid  
- having at least one of the following signs of possible frailty: 
unintentional weight loss, or decreased walking speed, or ≥1 fall during 
the previous year  
 
A total of 210 participants fulfilled the inclusion criteria and were included in 
the FINALEX study. These participant-caregiver dyads were randomized in 
blocks of 30 between April 28, 2008 and August 8, 2009. Computer-generated 
randomly allocated numbers received from a randomization center by 
telephone were used to perform the randomization. The identities of the 
potential participants were not known in the randomization center. A study 
nurse called the randomization center and read the names in the order they 
were on a printed list. The 210 participants were randomized into three groups 
each consisting of 70 dyads: home-based intervention group, group-based 
intervention group, and control group. Five participants died and eleven 
declined to participate immediately after randomization, resulting in 194 
participants in these analyses. The final numbers of participants in the 
FINALEX study were: home-based intervention group (N=68), group-based 
intervention group (N=61) and control group (N=65). Both intervention 
groups exercised for approximately one hour twice a week for one year, with 
similar training methods. In the present analyses the two intervention groups 
were merged into a single intervention group (N=129). The control group was 
the same as in the original FINALEX study. Figure 4 shows the flowchart of 











Table 6 shows baseline characteristics of the participants in the Helsinki 
Businessmen Study and in the FINALEX study.  
Table 6. Baseline characteristics of the participants in the Helsinki Businessmen Study and in the 
FINALEX study.  
 Helsinki Businessmen Study FINALEX study 
  Intervention groups Control group 
 N=480 N=129 N=65 
Age, mean (SD) 73 (4) 78 (5) 78 (5) 
Male, n (%) 480 (100) 80 (62) 39 (60) 
Married, n (%) 424 (88) 129 (100) 65 (100) 
Education <8 y, n (%) 0 (0) 48 (37) 29 (45) 
Charlson, mean (SD) 1.3 (1.4) 2.6 (1.8) 3.0 (1.7) 
Charlson=Charlson comorbidity index (Charlson et al. 1987); SD=Standard deviation 
 
4.2 ASSESSMENT METHODS  
4.2.1 ASSESSMENT METHODS IN THE HELSINKI BUSINESSMEN 
STUDY  
The included analyses of the Helsinki Businessmen Study are based on the 
postal questionnaires in 2000 and 2005 (both are shown in the appendices). 
In both years, the postal questionnaires were sent to the participants and they 
included a prepaid response letter. The participants completed the postal 
questionnaires themselves or in few cases with the help of relatives when 
needed.  
The postal questionnaires included details on demographics such as age, 
marital status, weight (kg), and BMI (kg/m²). Diseases (yes/no) were inquired 
about and confirmed in the register of the Social Insurance Institution of 
Finland. The Charlson comorbidity index was constructed as described 
(Charlson et al. 1987). Physical activity including exercise hours per week, 
current smoking status, and alcohol consumption behavior (type and amount) 
were inquired about.  
The 2000 questionnaire also included the RAND-36 (Hays & Morales 
2001). The RAND-36 instrument assesses individuals’ health-related quality 
of life (HRQoL) (Hays & Morales 2001). It consists of 36 items assessing eight 
health domains: physical functioning (ten items), role limitations caused by 
physical health problems (four items), role limitations caused by emotional 
problems (three items), social functioning (two items), emotional well-being 
(five items), energy/fatigue (four items), pain (two items), and general health 
perceptions (five items) (Hays & Morales 2001). A change in perceived health 
during the previous year is assessed via an additional single item (Hays & 
Morales 2001). Each item scores between 0 and 100, and then averages for 
each domain are calculated (Hays & Morales 2001). Validation has been 
investigated in several studies over the years (Samsa et al. 1999). A difference 
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of 3 to 5 points in a domain is suggested to be clinically important (Samsa et 
al. 1999). In this study RAND-36 was used in construction of frailty measures. 
In addition, weight change data from 1974 to 2000 were retrieved from the 
1974 and 2000 questionnaire data. The 2005 questionnaire contained a 
question on falls during the past year (yes, several times per year/yes, 1 or 2 
times per year/no). A participant was defined as a faller if they had fallen at 
least once during the past year. Weight change from 2000 to 2005 was 
calculated on the basis of answers in the questionnaires.  
The 15D HRQoL instrument was embedded in the 2005 questionnaire. The 
15D instrument assesses the HRQoL of the patients (Sintonen 2001). It is a 
comprehensive and generic instrument used to measure adults’ HRQoL. There 
are 15 dimensions in the 15D: hearing, vision, breathing, eating, sleeping, 
speech, mobility, usual activities, mental function, discomfort and symptoms, 
distress, depression, vitality, elimination, and sexual activity. The 15D score is 
generated by using a set of utility or preference weights, and the index scores 
are between 0 (lowest HRQoL) and 1 (highest HRQoL). The 15D is well 
comparable with other preference-based generic instruments (Hawthorne et 
al. 2001, Stavem et al. 2005). There has been systematic validation for the 15D 
since the 1970s in different population samples.  Development has progressed 
according to the feedback of both patients and experts. The 15D is normally 
filled in by the subject but it can also be filled in via an interview with the 
subject or their proxy. A difference of 0.02 to 0.03 in the 15D score between 
patient groups has been considered clinically significant (Sintonen 2001).  
Mortality data were retrieved from the Population Information System 
maintaining a register of all Finnish citizens, thus giving 100% coverage.  
The two phenotypic frailty measures HBS (Sirola et al. 2011) and WHI-OS 
(Woods et al. 2005) are based on Fried criteria (Fried et al. 2001). The FI 
measure includes physical, psychological, cognitive, and social dimensions 
(Mitnitski et al. 2001, Fisher 2005). The number and extent of the dimensions 
included have varied between studies (Song et al. 2010).  The FI was calculated 
as the number of conditions present divided by the number of items measured, 
which was 20 in Study I. Cut-off scores of ≥0.25 for frail, 0.08–0.249 for 
prefrail and <0.08 for not frail were used, as they have been used earlier (Song 










































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































4.2.2 ASSESSMENT METHODS IN THE FINALEX STUDY  
Those spousal dyads fulfilling the inclusion criteria (N=210) were invited to an 
appointment with study nurses. They were given written and oral information 
about the study and they gave their written informed consent. The spouses 
gave consent for the participants with reduced judgement capacity (Clinical 
Dementia Rating [CDR] scale >1). One study nurse interviewed the patient 
while another study nurse interviewed the spouse at the same time.  
All participants were evaluated by the study nurses at baseline and at three, 
six, and 12 months.  
Demographic factors (age, sex, education) were collected from the 
participants. They were assessed on their mobility and physical functioning as 
well as cognitive functioning. Diseases of the participants and types of 
medication were enquired about and they were verified from the medical 
records brought by the dyads. The Charlson comorbidity index was calculated 
(Charlson et al. 1987). This index gives a measure of the load and prognosis of 
comorbidities (Charlson et al. 1987). Participants’ height, weight and blood 
pressure were measured.  
The Mini Nutritional Assessment (MNA) measure served to assess the 
nutritional status of the participants (Guigoz et al. 2002, Guigoz 2006). The 
MNA consists of 18 questions (six for screening and twelve for assessment). 
For each question the lowest score is 0 and the highest score ranges from 1 to 
3. Total points come to 0 to 30, of which points <17 indicate malnutrition, 
points from 17 to 23.5 indicate risk of malnutrition, and points from 24 to 30 
indicate normal nutritional status. The MNA measure is shown in the 
appendices.  
The Functional Independence Measure (FIM) (Pollak et al. 1996) served to 
assess both physical and cognitive functioning. It was used at baseline and at 
three, six, and 12 months. The FIM consists of 18 categories of which five 
concern cognitive functioning and 13 concern physical functioning. Each 
category is rated on a scale from 1 to 7, in which 1 refers to total assistance 
required and 7 refers to full independence. The total score ranges from 18 to 
126 points. The lower the score, the more likely the person needs assistance 
(Pollak et al. 1996). 
A modified Short Physical Performance Battery (SPPB) (Guralnik et al. 
1994) served to evaluate the physical functioning of the participants. The SPPB 
measures physical functioning of the lower extremities and consists of three 
parts: 1) gait speed is measured over a distance of 2.4 meters which the person 
is asked to walk at their natural speed (in FINALEX the distance used was 10 
meters instead), 2) total time to rise from a chair and return to a seated 
position five times is measured (in FINALEX three times instead), and 3) 
balance is evaluated by examining the ability to stand with the feet together in 
side-by-side, semi-tandem, and tandem positions for a maximum of 10 
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seconds each (in FINALEX the maximum time was 15 seconds). The SPPB was 
evaluated as described (Guralnik et al. 1994) and is shown in the appendices.  
The Timed Up & Go test (Podsiadlo & Richardson 1991) also served to 
evaluate physical functioning. The test measures objectively the time in which 
the person rises from a chair, walks three meters, turns, walks back, and sits 
down again. Groups of <20 seconds, 20–29 seconds, and 30 seconds or more 
have been used (Podsiadlo & Richardson 1991). The time score correlates with 
balance and gait speed (Podsiadlo & Richardson 1991). The present study 
shows the scores in relation to incidence rate ratios (IRRs) of falls per 1-
standard deviation (1-SD).  
The participants’ cognitive status was evaluated by MMSE (Folstein et al. 
1975) and CDR (Hughes et al. 1982). MMSE evaluates orientation to time and 
place, registration, attention and calculation, recall, naming, repetition, and 
complex command. The total score ranges from 0 to 30, of which 0–11 points 
refer to severe dementia, 12–17 refer to moderate dementia, 18–23 refer to 
mild dementia/cognitive impairment, and 24–30 refer to normal cognitive 
functioning. The MMSE is shown in the appendices.  
CDR evaluates the stage of cognitive disorder and dementia and is based 
on interviews of the patient and his/her proxy, and clinical assessment. CDR 
consists of six parts: memory, orientation, judgment and problem solving, 
community affairs, home and hobbies, and personal care. Each part scores 0 
(no impairment), 0.5 (questionable impairment; not in personal care 
category), 1 (mild impairment), 2 (moderate impairment), or 3 points (severe 
impairment). The memory part defines the CDR stage. Other parts may shift 
the stage defined by the memory part by one level to a more severe or a milder 
stage. The CDR scores for dementia are as follows: 0 none, 0.5 very mild 
cognitive decline (possible dementia), 1 mild, 2 moderate, and 3 severe 
(Hughes et al. 1982). 
The Cornell Scale for Depression in Dementia was used to evaluate 
symptoms of depression (Alexopoulos et al. 1988). The scale consists of 19 
items including questions about mood-related signs, behavioral disturbances, 
physical signs, cyclic functions, and ideational disturbances. Evaluation is 
based on interviews of both patient and spouse or nursing staff member. All 
items are evaluated as either 0=absent, 1=mild or intermittent, or 2=severe. 
The total score ranges from 0 to 38, in which lower scores refer to no 
depression or mild depression symptoms and scores of 13 and higher refer to 
more severe depression (Alexopoulos et al. 1988). 
In Study II, the frailty measure was phenotype-based and consisted of five 
criteria: 1) unintentional weight loss was asked about from the spouse 
(yes/no), 2) exhaustion was based on the “lack of energy” item in the Cornell 
Scale for Depression (gets exhausted easily, is not able to sustain activity) 
(Alexopoulos et al. 1988), 3) low physical activity was based on the question 
“do you have an exercise hobby” (yes/no), 4) slow gait speed was defined as 
<0.85 m/s and measured in the SPPB test (Guralnik et al. 1994),  and 5) 
weakness was based on grip strength measured and adjusted for BMI (≤17 kg, 
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if BMI ≤23 kg/m²; ≤17.3 kg, if BMI 23–26 kg/m²; ≤18 kg, if BMI 26–29 
kg/m²; ≤21 kg, if BMI ≥29 kg/m²). As all participants had to have at least one 
of the signs of possible frailty (decreased walking speed, ≥1 fall during the 
previous 12 months, or unintentional weight loss), they were classified into 
either prefrail intervention (PRI) or prefrail control (PRC) groups (0 or 1 of the 
five criteria) or into advanced frailty intervention (AFI) and advanced frailty 
control (AFC) groups (2–5 of the five criteria).  
In baseline assessment, the spouses were asked about the participants’ 
possible falls in the previous year. Falls during the follow-up period of the 
study (12 months) were based on fall diaries kept by the spouses.  
Polypharmacy was defined as regularly taking ≥9 forms of systemic 
medication. Antihypertensives included medications with the Anatomical 
Therapeutic Chemical classification system of the World Health Organization 
(WHO ATC) codes (WHO 2017) C03 (diuretics), C07 (beta-blocking agents), 
C08 (calcium channel blockers) and C09 (agents acting on the renin-
angiotensin system). Psychotropics included medications with the WHO ATC 
codes N05A (antipsychotics), N05B (anxiolytics), N05C (hypnotics and 
sedatives) and N06A (antidepressants). Opioids included medications with 
the WHO ATC codes N02A (opioids). DAPs were defined according to the 
Anticholinergic Risk Scale (Rudolph et al. 2008) and B01AC07 
(dipyridamole), R05DA04 (codeine) and N02AX02 (tramadol) from the 
Anticholinergic Drug Scale (Carnahan et al. 2006) were also included.  
4.3 INTERVENTION IN THE FINALEX STUDY  
The FINALEX study consisted of two intervention arms: the home-based 
intervention group and the group-based intervention group. The home-based 
intervention group exercised one hour twice a week for one year at home. A 
physiotherapist supervised all training sessions. The group-based intervention 
group also exercised twice a week for one year. The sessions were held at 
daycare centers to which the participants were transported by taxis. Two 
physiotherapists supervised the sessions of ten participants. The visits to 
daycare centers lasted four hours (including lunch), of which individual 
training time was approximately one hour.  
The spouses of the participants in both intervention groups cooperated in 
the study and a few more intensive rehabilitation periods in institutional 
settings were organized if needed. Both intervention groups were assessed by 
a geriatrician and a plan for rehabilitation was drawn up. The geriatrician’s 
assessment ensured safety of the intervention. Home-based exercise training 
was tailored according to the participant’s needs, whereas the group-based 
intervention group exercised according to a preplanned exercise program 
consisting of strength, balance, multitasking, aerobic and endurance training. 
The intervention involved individually increasing weights during the study 
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period. The control group received normal community care; physiotherapy 
was also allowed.  
Study nurses assessed all groups at baseline, and at three, six and 12 
months. All groups were given information about AD, the symptoms and 
consequences of the disease, the possibilities of treatment and rehabilitation, 
and written advice on exercise, nutrition and vitamin D. Table 8 summarizes 
exercise intervention methods in the home-based and group-based exercise 
intervention groups.  
Table 8. Methods in home-based and group-based intervention in the FINALEX study.  
Component of 
training 
Home-Based Exercise Group Exercise 
Aerobic Pedal exerciser, exercise bike, 
Nordic walking outdoors 
Pedal exerciser, rowing machine, 
dancing, Nordic walking outdoors 
Strength Training with ankle and hand 
weights 
Training with various equipment in the 
gym 
Balance Training with balance pillows, 
climbing stairs, picking up items 
from floor, rising from floor 
Trampoline jumping, walking on 
balance line or beam, picking up items 
from floor level, climbing a ladder, 
bouncing a ball, rising from floor 
Executive functioning Throwing a ball accurately, dual-
tasking (e.g. singing while 
training, performing different 
functions with right and left 
hands while counting backward) 
Throwing a ball accurately, dual-
tasking (e.g. singing while training, 
performing different functions with 
right and left hands while counting 
backward) 
4.4 STATISTICAL ANALYSES  
The data are given as means with SDs, as counts and percentages, or as 
medians with interquartile ranges (IQRs). In Study I the differences between 
three frailty measures were assessed using generalized linear models with 
appropriate distribution and link function. Significance tests for estimates of 
all the models were based on robust standard errors to account for the 
clustering of participants.  
The Cochran–Armitage test and analysis of variance (ANOVA) with 
orthogonal polynomial contrast were used to test the linearity across the three 
frailty stages (Study I), and in Study III, when comparing those with none, one 
or ≥2 falls. In cases of violation of assumptions such as non-normality or when 
the theoretical distribution of the test statistics was unknown, the boostrap 
method was used (Studies I and II). The normalities of continuous variables 
were tested by using Shapiro–Wilk statistics (Studies I, II, III and IV). The t-
test, the Mann–Whitney U-test, the boostrap-type t-test or the Chi-square test 
served to test differences between groups at baseline, as appropriate (Studies 
II, III, and IV).  
Generalized linear mixed-models with unstructured correlation structure 
were used to analyze repeated measures. Fixed effects were group, time, and 
group-time interaction (Study II).  
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The product limit estimate (Kaplan–Meier) of the cumulative “survival” 
function was used as the basis of time-to-event analysis and the age-adjusted 
risk of mortality was estimated with the Cox proportional hazard model (Study 
I). Incidence rates of falls per 1000 person-years with 95% confidence 
intervals (CIs) were calculated, assuming Poisson distribution. Poisson 
regression models or negative binomial regression models, when appropriate, 
were used to calculate adjusted estimates of IRRs for falls (Studies II and III). 
The Lagrange multiplier test was used to test the assumptions of over-
dispersion in the Poisson model (Studies II, III and IV). In Study III the 
nonlinear relationship between MMSE data and number of drugs vs. the 
incidence of falls was assessed using Poisson regression including quadratic 
terms. Furthermore, in Study IV Poisson regression models with count of fall 
events were used to model the relationship between exercise and drugs and 
these models were adjusted for age, gender, and FIMmotor (motor part of the 
FIM).  
Stata 14.1 and 15.0 statistical packages (StataCorp LP, College Station, TX, 
USA) were used for the analyses.  
4.5 ETHICAL CONSIDERATIONS  
The Ethics Committee of Helsinki University Hospital approved the study 
protocols, and all participants provided informed consent. The Helsinki 
Businessmen Study began in the 1960s and at that time formalities such as 
trial registration were rudimentary. The participants of the Helsinki 
Businessmen Study were told of the design and purpose of the trial; they all 
gave oral consent and took part voluntarily in the trial. In the FINALEX study 




5 RESULTS  
5.1 CHARACTERISTICS OF PARTICIPANTS IN THE 
HELSINKI BUSINESSMEN STUDY (STUDY I)  
The baseline characteristics of the Helsinki Businessmen Study participants 
are presented in Table 9. There were 480 participants in the study. Their mean 
age was 73 years. All Helsinki Businessmen Study participants were male and 
highly educated. Their mean BMI was slightly over 25 kg/m2. Their mean 
Charlson comorbidity index was 1.3.  
Table 9. Baseline characteristics in 2000 of frail participants according to the Helsinki 
Businessmen Study (HBS) measure (Sirola et al. 2011), the modified Women’s Health Initiative 
Observational Study (WHI-OS) measure (Woods et al. 2005), and the Frailty Index (FI) measure 
(Mitnitski et al. 2001), and characteristics of all participants (ALL).  








Age, mean (SD) 75 (5) 75 (5) 74 (4) 73 (4) 
Married, n (%) 31 (89) 30 (86) 76 (88) 424 (88) 
Body Mass Index, mean (SD) 24.2 (3.5) 24.0 (3.4) 25.9 (3.4) 25.5 (3.1) 
Weight, kg, mean (SD) 77.7 (10.7) 77.9 (11.2) 82.3 (11.5) 81.4 (4.0) 
Cancer, n (%) 8 (23) 7 (20) 17 (20) 62 (13) 
Cerebrovascular disorder, n (%) 7 (20) 8 (23) 25 (29) 42 (9) 
Chronic obstructive pulmonary disease, n (%) 7 (20) 6 (17) 15 (17) 35 (7) 
Coronary heart disease, n (%) 9 (26) 10 (29) 33 (38) 79 (16) 
Diabetes, n (%) 5 (14) 5 (14) 20 (23) 49 (10) 
Heart failure, n (%) 8 (23) 10 (29) 22 (26) 57 (12) 
Memory disturbance, n (%) 13 (37) 15 (43) 38 (44) 72 (15) 
Musculoskeletal disease, n (%) 17 (49) 17 (49) 44 (51) 116 (24) 
Psychiatric illness, n (%) 3 (9) 4 (11) 9 (10) 18 (4) 
Charlson, mean (SD) 2.7 (1.8) 2.8 (1.8) 3.0 (1.6) 1.3 (1.4) 
Statin user, n (%) 2 (6) 3 (9) 19 (22) 70 (15) 
Exercises regularly, n (%) 14 (40) 14 (40) 62 (72) 408 (85) 
Exercise hours/week, median (IQR) 0 (0–4) 0 (0–3) 3 (0–6) 5 (3–7) 
Smokers, n (%) 5 (14) 6 (17) 8 (9) 38 (8) 
Charlson=Charlson comorbidity index (Charlson et al. 1987); IQR= Interquartile range; 
SD=Standard deviation 
 
The frail participants according to the HBS frailty measure, the modified WHI-
OS frailty measure and the FI frailty measure were old, frequently had diseases 
such as cancer, cerebrovascular disorder, chronic obstructive pulmonary 
disease (COPD), heart diseases, memory disturbances and psychiatric 
illnesses, as well as musculoskeletal diseases, and they exercised for relatively 
few hours in a week.  
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5.2 PROGNOSIS OF FRAILTY (STUDY I)  
In Study I, the three frailty measures (HBS, WHI-OS, FI) identified partly 
overlapping but not all the same men as frail. Both HBS and WHI-OS 
measures identified 35 (7.3%) participants as frail whereas the FI identified 86 
(17.9%) as frail. A total of 102 men were identified as frail by at least one frailty 
measure, and 21 men were identified as frail by all three frailty measures. 
Figure 5 presents the overlapping of the frail participants according to the 
three measures at the 2000 baseline in a Venn diagram.  
  
Figure 5. A Venn diagram showing overlapping of the frail participants according to the Helsinki 
Businessmen Study (HBS) measure (Sirola et al. 2011), the modified Women’s Health Initiative 
Observational Study (WHI-OS) measure (Woods et al. 2005), and the Frailty Index (FI) measure 
(Mitnitski et al. 2001) at the 2000 baseline.  
Fallers in 2005  
 
Figure 6 shows the number of fallers in the year 2000 frailty stage groups 
according to all three frailty measures. For all three compared measures there 
were higher proportions of fallers in frail groups than in prefrail or not frail 
groups in 2005. The difference was significant in all the measures. The 
proportions of fallers in the HBS groups were 47.1% (N=8) [95% CI: 23.0 to 
72.2] in the frail group, 26.4% (N=51) [95% CI: 20.4 to 33.2] in the prefrail 
group, and 20.7% (N=35) [95% CI: 14.9 to 27.6] in the not frail group 
(p=0.027). The corresponding values in the WHI-OS groups were 52.9% 
(N=9) [95% CI: 27.8 to 77.0] in the frail group, 25.8% (N=43) [95% CI: 19.3 to 
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33.1] in the prefrail group, and 21.5% (N=42) [95% CI: 16.0 to 28.0] in the not 
frail group (p=0.023). In the FI groups, they were 40.7% (N=22) [95% CI: 27.6 
to 55.0] in the frail group, 22.9% (N=35) [95% CI: 16.5 to 30.4] in the prefrail 
group, and 21.5% (N=37) [95% CI: 15.6 to 28.4] in the not frail group 
(p=0.016).  
  
Figure 6. Numbers of fallers in the year 2000 frailty stage groups according to the Helsinki 
Businessmen Study (HBS) measure (Sirola et al. 2011), the modified Women’s Health Initiative 
Observational Study (WHI-OS) measure (Woods et al. 2005), and the Frailty Index (FI) measure 
(Mitnitski et al. 2001).  
Weight change from 2000 to 2005  
 
Figure 7 shows weight changes from 2000 to 2005. All the groups tended to 
lose weight, but no significant differences existed between the various frailty 
groups according to any of the three measures. According to the HBS measure 
the mean weight change was -0.6 kg [95% CI: -2.6 to 1.4] in the frail group, -
1.0 kg [95% CI: -1.5 to -0.4] in the prefrail group, and -0.8 kg [95% CI: -1.4 to 
-0.1] in the not frail group (p=0.79). The corresponding values as regards the 
modified WHI-OS measure were -0.5 kg [95% CI: -2.5 to 1.5] in the frail group, 
-1.0 kg [95 % CI: -1.6 to -0.4] in the prefrail group, and -0.7 kg [95% CI: -1.3 to 
-0.2] in the not frail group (p=0.69). Regarding the FI, the figures were -1.4 kg 
[95% CI: -2.5 to -0.3] in the frail group, -0.7 kg [95% CI: -1.3 to -0.0] in the 





Figure 7. Weight changes from 2000 to 2005 in the year 2000 frailty stage groups according to 
the Helsinki Businessmen Study (HBS) measure (Sirola et al. 2011), the modified Women’s 
Health Initiative Observational Study (WHI-OS) measure (Woods et al. 2005), and the Frailty 
Index (FI) measure (Mitnitski et al. 2001).  
Quality of life in 2005  
 
Figure 8 shows the QoL in 2005 according to the 15D instrument (Sintonen 
2001). With all three measures the HRQoL was found to be lowest in the frail 
groups. In connection with the HBS measure the mean 15D scores were 0.76 
[95% CI: 0.71 to 0.81] in the frail group, 0.87 [95% CI: 0.86 to 0.88] in the 
prefrail group, and 0.92 [95% CI: 0.91 to 0.93] in the not frail group (p<0.001, 
adjusted for age). The corresponding values as regards the modified WHI-OS 
measure were 0.74 [95% CI: 0.70 to 0.78] in the frail group, 0.86 [95 % CI: 
0.85 to 0.88] in the prefrail group, and 0.92 [95% CI: 0.91 to 0.93] in the not 
frail group (p<0.001, adjusted for age). Regarding the FI, the figures were 0.78 
[95% CI: 0.75 to 0.81] in the frail group, 0.88 [95% CI: 0.87 to 0.90] in the 
prefrail group, and 0.92 [95% CI: 0.92 to 0.93] in the not frail group (p<0.001, 
adjusted for age).  
Mortality from 2000 to 2005  
 
Figure 9 shows mortality in different stages of frailty according to the three 
measures. With all the three measures mortality was greatest in the frail 
groups. In connection with the HBS measure the mortality rate was 51.4% 
[95% CI: 36.3 to 68.6] in the frail group, 19.5% [95% CI: 15.1 to 25.0] in the 
prefrail group, and 8.8% [95% CI: 5.5 to 13.7] in the not frail group (p<0.001, 
adjusted for age). The corresponding values as regards the modified WHI-OS 
measure were 51.4% [95% CI: 36.3 to 68.6] in the frail group, 21.3% [95% CI: 
16.4 to 27.3] in the prefrail group, and 8.5% [95% CI: 5.5 to 13.0] in the not 
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frail group (p<0.001, adjusted for age). Regarding the FI, the figures were 
36.1% [95% CI: 26.9 to 47.1] in the frail group, 19.1% [95% CI: 14.2 to 25.3] in 
the prefrail group, and 8.0% [95% CI: 5.0 to 12.7] in the not frail group 
(p<0.001, adjusted for age).  
  
Figure 8. Quality of life (according to the 15D measure (Sintonen 2001)) in 2005 in the year 2000 
frailty stage groups according to the Helsinki Businessmen Study (HBS) measure (Sirola et al. 
2011), the modified Women’s Health Initiative Observational Study (WHI-OS) measure (Woods et 
al. 2005), and the Frailty Index (FI) measure (Mitnitski et al. 2001).  
  
Figure 9. Mortality from 2000 to 2005 in the year 2000 frailty stage groups according to the 
Helsinki Businessmen Study (HBS) measure (Sirola et al. 2011), the modified Women’s Health 
Initiative Observational Study (WHI-OS) measure (Woods et al. 2005), and the Frailty Index (FI) 
measure (Mitnitski et al. 2001).  
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5.3 CHARACTERISTICS OF THE PARTICIPANTS IN THE 
FINALEX STUDY (STUDIES II, III AND IV) 
The baseline characteristics of the 194 FINALEX participants are presented in 
Table 10. The participants in the intervention and control groups are shown 
separately. Their mean age was 78 years. Of the participants, three out of five 
were male. Two in five participants had less than eight years of education. 
Mean BMI was slightly over 25 kg/m2. The participants used seven drugs on 
average and the Charlson comorbidity index was three. There were no 
significant differences in characteristics between the intervention and control 
groups.  






Men, n (%) 80 (62) 39 (60) 0.79 
Age (years), mean (SD) 78 (5) 78 (5) 0.75 
Education <8 years, n (%) 48 (37) 29 (45) 0.32 
MNA, mean (SD) 23 (2) 22 (2) 0.29 
BMI, kg/m2, mean (SD) 25.9 (3.4) 25.0 (3.9) 0.12 
Blood pressure, mean (SD)    
   Systolic 150 (25) 150 (27) 0.97 
   Diastolic 77 (12) 75 (12) 0.22 
Number of drugs, mean (SD) 6.5 (3.6) 6.6 (3.0) 0.94 
CDR, n (%)   0.72 
   0.5–1 44 (34) 22 (34)  
   2 61 (47) 34 (52)  
   3 24 (19) 9 (14)  
Charlson index, mean (SD) 2.6 (1.8) 3.0 (1.7) 0.12 
SPPB total, mean (SD) 9.6 (2.3) 9.8 (2.0) 0.23 
FIM Total, mean (SD) 88 (19) 88 (18) 0.85 
Vision problem, n (%) 9 (7) 8 (12) 0.22 
Fallen in previous year, n (%) 48 (37) 32 (49) 0.11 
*Differences between groups were tested by t-test, bootstrap-type t-test or Chi-square test; 
BMI=body mass index; CDR=Clinical Dementia Rating scale (Hughes et al. 1982); Charlson 
index=Charlson comorbidity index (Charlson et al. 1987); FIM=Functional Independence Measure 
(Pollak et al. 1996); MNA=Mini-Nutritional Assessment (Guigoz et al. 2002);   SD=standard 
deviation; SPPB=Short Physical Performance Battery (Guralnik et al. 1994)  
  
5.4 FRAILTY IN MODIFYING THE EFFECTS OF 
EXERCISE AMONG PEOPLE WITH ALZHEIMER 
DISEASE (STUDY II)  
The participants (129 in the intervention groups and 65 in the control groups) 
were classified into the prefrail (0–1 criteria present) groups PRI (N=73) and 
PRC (N=38), and advanced frailty (2–5 criteria present) groups AFI (N=56) 





Effects of exercise intervention on physical function  
 
Figure 10, left panel, shows the changes in FIM scores in the prefrail 
intervention (PRI) and control (PRC) groups during the 12 months of follow-
up. FIM scores showed deterioration in both the PRI and PRC groups. 
However, the rate of decline was slower in the PRI group than in the PRC 
group. The mean difference between the PRI and PRC groups was significant 
at 12 months, as the changes in FIM scores were -6.6 [95% CI: -8.6 to -4.5] in 
the PRI group and -11.1 [95% CI: -13.9 to -8.3] in the PRC group; p=0.010 
(adjusted for sex, age and comorbidities).  
Figure 10, right panel, shows the changes in FIM scores in the advanced 
frailty intervention (AFI) and control (AFC) groups during the 12 months of 
follow-up. FIM scores showed deterioration in both the AFI and AFC groups. 
However, the rate of decline was slower in the AFI group than in the AFC 
group. The mean difference between the AFI and AFC groups was significant 
at six months (FIM score change, -8.1 [95% CI: -11.1 to -5.2] in the AFI group 
and -15.5 [95% CI: -20.0 to -11.1] in the AFC group; p=0.007 adjusted for age, 
sex and comorbidities) and at 12 months (FIM score change, -8.9 [95% CI: -
11.9 to -5.9] in the AFI group and -15.3 [95% CI: -20.2 to -10.3] in the AFC 
group; p=0.031 adjusted for sex, age and comorbidities).  
  
Figure 10. Changes in Functional Independence Measure (FIM) scores (Pollak et al. 1996) in 
intervention and control groups within the prefrail and advanced-frailty groups.  
Effects of exercise intervention on falls  
 
Figure 11 shows the effects of exercise intervention on falls during the 12 
months of follow-up. Among prefrail participants (Figure 11, left panel) the 
PRI group had a significantly lower fall rate (1.14 falls/person-year [95% CI: 
0.90 to 1.43]) than the PRC group (1.82 falls/person-year [95% CI: 1.40 to 
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2.32]). The IRR was 0.63 (95% CI: 0.45 to 0.89; p=0.008, adjusted for age, 
sex and comorbidities).  
Among advanced-frailty participants (Figure 11, right panel) the AFI group 
had a significantly lower fall rate (2.15 falls/person-year [95% CI: 1.76 to 2.59]) 
than the AFC group (5.32 falls/person-year [95% CI: 4.36 to 6.44]). The IRR 
was 0.43 (95% CI: 0.33 to 0.57; p<0.001 adjusted for age, sex and 
comorbidities).  
  
Figure 11. Number of falls per person-years (pyrs) in intervention and control groups within the 
prefrail and advanced frailty groups during the 12 months of follow-up.  
In addition, a novel table (Table 11) shows the numbers of fallers in 
intervention and control groups among prefrail and advanced-frailty 
participants. The numbers show that eight prefrail participants had to receive 
the intervention to prevent one of them becoming a faller (number needed to 
treat [NNT] = 7.9 [95% CI: 3.2 to 14.4]). Respectively, three advanced-frailty 
participants had to receive the intervention to prevent one of them becoming 
a faller (NNT = 2.6 [95% CI: 1.8 to 5.8]). The numbers of fallers per person-
years are also shown in Table 11. Among prefrail participants the intervention 
group had 0.51 [95% CI: 0.35 to 0.72] fallers per person-years and the control 
group had 0.62 [95% CI: 0.39 to 0.93] fallers per person-years (IRR=0.83 
[95% CI: 0.48 to 1.42]). Among advanced-frailty participants the intervention 
group had 0.50 [95% CI: 0.33 to 0.73] fallers per person-years and the control 
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group had 1.09 [95% CI: 0.69 to 1.63] fallers per person-years (IRR=0.46 [95% 
CI: 0.26 to 0.80]).  
Table 11. Numbers of fallers in respect of years of exposure shown separately in intervention 





Number of participants   
   Prefrail 73 38 
   Advanced frailty 56 27 
Total years of exposure   
   Prefrail 64.8 35.8 
   Advanced frailty 52.2 21.2 
Fallers, n (%)   
   Prefrail 33 (45.2) 22 (57.9) 
   Advanced frailty 26 (46.4) 23 (85.2) 
Number of fallers per person years (95% CI)   
   Prefrail 0.51 (0.35 to 0.72) 0.62 (0.39 to 0.93) 
   Advanced frailty 0.50 (0.33 to 0.73) 1.09 (0.69 to 1.63) 
 
5.5 FALLS AMONG PATIENTS WITH DEMENTIA 
(STUDIES III AND IV)  
Of the 194 participants in the study, 103 did not fall during the 12 months of 
follow-up, 34 fell once, and 57 fell two or more times (Figure 12). The persons 
having experienced a fall or falls in the preceding year of the study fell more 




Figure 12. Number of participants according to the 
number of falls during the 12 months of follow-up. White 
parts of the columns reflect the persons with no falls in 
the year preceding the follow-up period; gray parts reflect 






The total number of falls was 355, of which half happened in the afternoon and 
the rest happened equally during evenings, nights and mornings. Stumbling 
(n=61), dizziness (n=37), and weakness of legs (n=18) were the most common 
reasons for a fall as reported by spouses of participants. However, the spouses 
could not state the cause for falling in most cases (Figure 13).  
  
Figure 13. Numbers of cases and reasons for falling.  
There were 123 injuries, 50 emergency department visits, and 13 fractures as 
consequences of the falls (Figure 14).  
  
Figure 14. Numbers of falls, injuries, visits to emergency departments and fractures.  
Protective and risk factors of falls  
 
A prior fall (or falls) during the year preceding the study was a great risk factor 
of falls (IRR 2.71 [95% CI: 2.13 to 3.44]). In respect of MMSE, those 




Figure 15. Incidence of falls per person-years (pyrs) according to the Mini-Mental State 
Examination (MMSE) score (Folstein et al. 1975).  
An increasing number of regular drugs was associated with a greater incidence 
of falls (Figure 16).  
  
Figure 16. Incidence of falls per person-years (pyrs) according to the number of regularly used 
drugs.  
The associations between physical features and the IRRs of falls (per 1-SD; 
adjusted for age, sex, and intervention) are presented in Figure 17. Better 
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scores for all the measured physical features had a protective association as 
regards falls. Higher FIM motor scores (IRR 0.49, 95% CI 0.45 to 0.54), SPPB 
scores (IRR 0.62, 95% CI 0.56 to 0.69), higher points in the SPPB balance test 
(IRR 0.79, 95% CI 0.70 to 0.88), faster walking speed (IRR 0.54, 95% CI 0.48 
to 0.60), better scores in the Timed Up and Go test (IRR 0.46, 95% CI 0.3 to 
0.54), and higher MNA scores (IRR 0.68, 95% CI 0.63 to 0.75) at baseline were 
all associated with a lower number of falls.  
  
Figure 17. Associations between physical features and incidence rate ratios (IRRs) of falls (per 
1-SD; adjusted for age, sex, and intervention). Balance=Balance test in SPPB; FIM=Functional 
Independence Measure (Pollak et al. 1996); MNA=Mini-Nutritional Assessment (Guigoz et al. 
2002); SD=standard deviation; SPPB=Short Physical Performance Battery (Guralnik et al. 1994); 
Up&Go=Timed Up & Go test measuring chair mobility and walking (Podsiadlo & Richardson 
1991); Walking speed=walking speed test in SPPB.  
Figure 18 presents the relationship between diseases and the IRRs of falls 
(adjusted for age, sex, and intervention). Of the diseases, COPD (IRR 2.18, 
95% CI 1.33 to 3.56), osteoarthritis (IRR 1.86, 95% CI 1.31 to 2.63), and 
diabetes mellitus (IRR 1.59, 95% CI 1.23 to 2.06) increased the IRR, whereas 
cancer (IRR 0.56, 95% CI 0.40 to 0.80) and hypertension (IRR 0.67, 95% CI 
0.53 to 0.85) seemed to have a protective association with falls.  
  
Figure 18. The association between diseases and the incidence rate ratios (IRRs) of falls 
(adjusted for age, sex, and intervention). CHD=coronary heart disease; COPD=chronic 
obstructive pulmonary disease; DM=diabetes mellitus  
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Figure 19 presents the relationship between drugs and the IRRs of falls 
(adjusted for age, sex, and intervention). Opioids (IRR 4.27, 95% CI 2.92 to 
6.24), psychotropics (IRR 1.69, 95% CI 1.34 to 2.12), and DAPs (IRR 1.51, 95% 
CI 1.19 to 1.92) increased the IRR, whereas antihypertensive medication (IRR 
0.68, 95% CI 0.54 to 0.85) had a protective association with falls.  
  
Figure 19. The effects of drugs on the incidence rate ratios (IRRs) of falls (adjusted for age, sex, 
and intervention).  
Exercise modifies the risk of falls associated with fall-related 
drugs 
 
The association between drugs and falls was compared in the intervention and 
control participants. Figure 20 presents the IRRs of falls during the 12 months 
of follow-up among participants with and without antihypertensives, 
psychotropics, DAPs, or polypharmacy, in intervention and control 
participants. (The IRRs and 95% CIs are crude figures.)  
Among participants without antihypertensives, the control group had 0.9 
falls per person-year (95% CI 0.6 to 1.2) and the intervention group had 1.2 
falls per person-year (95% CI 1.0 to 1.4). Among participants with 
antihypertensives, the control group had 1.5 falls per person-year (95% CI 1.2 
to 1.8) and the intervention group had 0.5 falls per person-year (95% CI 0.4 to 
0.6) (p=0.067 for medication, p<0.001 for group, p<0.001 for interaction).  
Among participants without psychotropics, the control group had 0.8 falls 
per person-year (95% CI 0.6 to 1.0) and the intervention group had 0.7 falls 
per person-year (95% CI 0.6 to 0.9). Among participants with psychotropics, 
the control group had 2.0 falls per person-year (95% CI 1.6 to 2.5) and the 
intervention group had 0.7 falls per person-year (95% CI 0.6 to 0.9) (p=0.071 
for medication, p<0.001 for group, p<0.001 for interaction).  
Among participants without DAPs, the control group had 1.2 falls per 
person-year (95% CI 1.0 to 1.4) and the intervention group had 0.6 falls per 
person-year (95% CI 0.5 to 0.7). Among participants with DAPs, the control 
group had 1.5 falls per person-year (95% CI 1.0 to 2.1) and the intervention 
group had 1.1 falls per person-year (95% CI 0.8 to 1.3) (p=0.014 for 
medication, p<0.001 for group, p=0.97 for interaction). 
Among participants without polypharmacy, the control group had 1.0 falls 
per person-year (95% CI 0.8 to 1.3) and the intervention group had 0.6 falls 
per person-year (95% CI 0.5 to 0.8). Among participants with polypharmacy, 
(≥9 regular drugs) the control group had 1.9 falls per person-year (95% CI 1.4 
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to 2.4) and the intervention group had 1.0 falls per person-year (95% CI 0.8 to 
1.3) (p=0.23 for medication, p<0.001 for group, p=0.17 for interaction).  
  
Figure 20. The incidence rate ratios of falls during the 12 months of follow-up per person-years 
(pyrs) among participants with and without antihypertensives, psychotropics, drugs with 
anticholinergic properties, or polypharmacy, in intervention and control participants.  
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6 DISCUSSION  
6.1 MAIN FINDINGS  
Both the HBS and the modified WHI-OS (physical frailty) measures identified 
7.3% of the men as frail, whereas the FI identified significantly more men as 
frail (17.9%). The men identified as frail by various measures overlapped only 
moderately. All three frailty measures predicted more fallers, poorer HRQoL, 
and greater mortality among the frail men than among those who were prefrail 
or robust. The HBS and WHI-OS measures predicted a higher mortality rate 
in the frail group than did the FI measure. The findings suggest that various 
frailty measures can be used to identify people at risk, and they may be based 
on a simple questionnaire. All of them can be used to predict major outcomes 
such as mortality, HRQoL, and falls.  
The results of the FINALEX study suggest that long-term and intensive 
exercise intervention may significantly slow down the decline of physical 
functioning in persons with AD, independently of the stage of frailty. The 
number of falls was also significantly reduced among both advanced frailty 
and prefrail participants in the intervention groups compared with their 
respective control groups.  
Half of the falls in the FINALEX study occurred in the afternoon and the 
most commonly stated reasons for falls were stumbling, dizziness, and 
weakness of the legs. Among persons with AD, good nutritional status and 
physical functioning showed a protective association against falls. Regular use 
of DAPs, psychotropics, and opioids, and a higher total number of drugs used 
were associated with a greater number of falls. Certain diseases (osteoarthritis, 
diabetes, and COPD) were also associated with a greater number of falls. 
Unexpectedly, both hypertension and use of antihypertensive medication were 
associated with a lower number of falls. Participants with an MMSE score of 
around ten points were more prone to fall than those with lower or higher 
MMSE scores.  The risk of falls among persons with AD using psychotropic 
medication or antihypertensive medication was significantly favorably 
modified by exercise intervention. However, exercise intervention did not 








6.2 PROGNOSIS OF FRAILTY  
In Study I, the baseline characteristics of the Helsinki Businessmen Study 
showed that the frail men, according to the HBS measure (Sirola et al. 2011), 
the modified WHI-OS measure (Woods et al. 2005), and the FI measure 
(Mitnitski et al. 2001) had several comorbidities. However, the frail 
participants according to the HBS and modified WHI-OS measures showed 
lower exercise levels, more weight loss, and lower BMI compared with frail 
individuals according to the FI measure. These baseline characteristics of 
participants according to both modified Fried criteria (HBS and modified 
WHI-OS) and the FI measure present similar features of frailty to those 
described previously, as the frail participants were older, had lower BMI, had 
more comorbidities according to the Charlson comorbidity index (Charlson et 
al. 1987), had more severe memory disturbances, and had more 
musculoskeletal diseases than prefrail and not frail participants (Fried et al. 
2001, Rockwood et al. 2004, Woods et al. 2005). This suggests that these 
questionnaire-based frailty measures can be used to identify frail persons.  
The prevalence of frailty in Study I was higher when investigated with the 
FI than with the two phenotypic measures. Both phenotype-based measures 
(HBS and modified WHI-OS) revealed a frailty prevalence of 7%, which is 
consistent with the results of earlier studies involving Fried criteria (Collard et 
al. 2012). There were only small differences between HBS and modified WHI-
OS measures. However, only 70.7% of the men identified as frail by HBS and 
modified WHI-OS measures overlapped. The finding suggests that defining 
frailty is very challenging and it is highly important to cautiously choose the 
appropriate measure to assess frailty. The prevalence of frailty was 18% 
according to the FI, being similar to the result in a previous study involving 
the same measure (Rockwood et al. 2004). In line with the results of an earlier 
study (Collard et al. 2012), the FI yielded a greater prevalence of frailty than 
the physical frailty measures. In a systematic review the prevalence of frailty 
varied from 4.0% to 59.1% among home-dwelling persons, according to 
various frailty definitions (Collard et al. 2012). Studies involving physical 
frailty definitions such as the Fried criteria (Fried et al. 2001) and its 
modifications (Collard et al. 2012) yielded the lowest prevalence values. Two 
recent studies on various frailty measures revealed that phenotype-based 
measures identified fewer participants as frail than the FI measure 
(Malmstrom et al. 2014, Widagdo et al. 2015), as in Study I. The prevalence 
rate yielded by the FI with only 20 items in Study I is similar to those in studies 
involving FIs with 39 (Widagdo et al. 2015) or 25 (Malmstrom et al. 2014) 
items. This similarity in frailty prevalence values between these studies 
suggests that the FI can also contain only 20 items.  
The two phenotype-based frailty measures and the FI measure compared 
in Study I predicted more fallers, poorer HRQoL, and greater mortality among 
frail men than among prefrail and not frail men. Previous studies have yielded 
similar findings, as found separately with the Fried criteria (Fried et al. 2001, 
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Ensrud et al. 2007, Widagdo et al. 2015, Kojima et al. 2016b), with the WHI-
OS measure (Woods et al. 2005), with the HBS measure (Sirola et al. 2011), 
and with the FI measure (Mitnitski et al. 2001, Rockwood & Mitnitski 2007, 
Fang et al. 2012, Hubbard et al. 2014, Widagdo et al. 2015). The prognostic 
significance of the three frailty measures did not differ from each other as 
regards falls and HRQoL, but the mortality rate was lower in the frail group 
according to the FI measure compared with the frail groups according to the 
HBS and modified WHI-OS measures. There were no differences in weight 
change among the different frailty stages according to any of the compared 
frailty measures. Weight change is associated with frailty (Fried et al. 2001), 
but to my knowledge only one study (Sirola et al. 2011) has been carried out to 
investigate whether or not frailty predicts weight change, and there were no 
significant associations.  
These findings justify all these definitions of frailty. Various measures 
approach the concept of frailty from different perspectives but still predict 
important outcomes. This study does not indicate a preference towards any of 
these frailty measures over the others. All of them offer prognostic validity 
albeit they identify different persons as frail. Any of them can be applied 
depending on the intended use. The FI might be used when needing a sensitive 
measure, whereas phenotype-based measures could be better options when 
screening for persons in need of exercise intervention.  
6.3 FRAILTY IN MODIFYING THE EFFECTS OF 
EXERCISE IN DEMENTIA  
Among participants in the FINALEX study frailty status was consistently and 
logically associated with gender, physical functioning, and stage of dementia. 
The baseline characteristics of the persons in our advanced frailty and prefrail 
groups were comparable to those in previous studies (Gillette-Guyonnet et al. 
2000, Fried et al. 2001, Robertson et al. 2013). There were fewer females in 
the prefrail groups and the participants used less medication than those in the 
advanced frailty groups. Also, in line with the findings in previous studies 
(Robertson et al. 2013) the results of the FINALEX study suggested that frailty 
becomes more prevalent when dementia advances. Malnutrition is common 
among frail persons (Cadore et al. 2013b)), and in this study the proportions 
of well-nourished participants were lower in the advanced frailty groups than 
in the prefrail groups.  
It has been suggested that exercise benefits frail persons by improving 
physical functioning (Chin A Paw et al. 2008, Theou et al. 2011, Chou et al. 
2012), which is in line with the finding in Study II. Other researchers have 
suggested that exercise intervention could benefit prefrail persons more than 
frail persons (Faber et al. 2006). In contrast to this finding, exercise 
intervention seemed to benefit the AFI group even earlier than the PRI group 
in respect of FIM score changes. The baseline FIM scores showed that the PRI 
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group had better physical function than the AFI group at the beginning of the 
study. Thus, for the AFI group there was a greater potential to enhance 
physical function. However, in line with findings in this study, a post-hoc 
analysis of the LIFE-P study suggested that exercise intervention benefited 
frail persons more than non-frail persons (Cesari et al. 2015). In the present 
study, the number of falls was significantly lower in the PRI and AFI groups 
than in the PRC and AFC groups. Previous studies have shown similar results 
in reducing the number of falls via exercise intervention (Cadore et al. 2013b). 
Such benefits in both intervention groups probably resulted from diverse, 
frequent, and long-term exercise intervention including balance training, 
which has also showed the most benefit in previous studies (Theou et al. 2011).  
6.4 FALLS AMONG PARTICIPANTS WITH DEMENTIA  
In Study III all the FINALEX participants were classified into groups of none, 
one, and two or more falls. Participants in the group of two or more falls were 
older, their systolic blood pressure was lower, vision problems were more 
common, and they had more severe dementia according to CDR than those 
with no falls or only one. Also, their mobility limitations according to SPPB 
rating, and physical functioning according to FIM were worse than among 
groups of no falls or only one. Earlier studies in which non-fallers and fallers 
have been compared have revealed similar characteristics (Horikawa et al. 
2005, Salva et al. 2012, Meuleners et al. 2016).  
Consistent with previous research findings (Allan et al. 2009, Salva et al. 
2012, Meuleners et al. 2016) a fall history was a risk factor of falls. An MMSE 
score in the range of 22–30 was a risk factor of falls in older persons with 
subtle cognitive impairment in a previous study (Gleason et al. 2009). 
However, the present study also involved persons with very low MMSE scores 
and the results suggest that persons scoring around ten points in MMSE are 
the most prone to falls. There were fewer falls among persons with extremely 
low MMSE scores, probably because they walk less.  
The findings in this study indicate that better physical functioning, and 
lower mobility limitations are protective factors against falls, which is in line 
with the results of previous studies (AGS 2001, Allan et al. 2009, Salva et al. 
2012). A higher MNA score was a protective factor in this study, and previously 
the MNA score has been found to be significantly lower among fallers than 
non-fallers (Salva et al. 2012).  
Osteoarthritis, COPD, and diabetes mellitus (DM) were risk factors of falls 
in this study. Arthritis has been found to be a risk factor of falls among older 
people (AGS 2001). A systematic review and meta-analysis showed diabetes to 
be a fall risk factor (Yang et al. 2016), which is in accordance with the finding 
in this study among people with AD. COPD was found to be a fall risk factor in 
a study among older women (Lawlor et al. 2003). The present findings indicate 
that these diseases may also be risk factors of falls among people with AD.  
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Psychotropics and polypharmacy have shown strong risk associations with 
falls among older people (AGS 2011). Accordingly, in the present study the risk 
of falls increased when the number of drugs used increased. In line with the 
results of other studies among persons with dementia (Horikawa et al. 2005, 
Kudo et al. 2009), psychotropics increased the risk of falls in this study. An 
important finding in this study was the fact that the use of opioids appeared to 
be a major risk factor of falls. A previous systematic review included one study 
(Kelly et al. 2003) in which opioids were associated with falls and one study 
(Ensrud et al. 2002) without this association (Hartikainen et al. 2007). 
Another study revealed no significance difference between users and non-
users of opioids among community-dwelling older men (Krebs et al. 2016). 
One study on the association between opioids and falls among persons with 
AD showed an increased risk of falls in crude numbers, but the risk did not 
persist after adjustment for occupational social class (Tolppanen et al. 2016).  
In this study both hypertension and antihypertensive medication had a 
protective association as regards falls, which is in contrast to earlier research 
data (Hartikainen et al. 2007, Gangavati et al. 2011). Symptomatic orthostatic 
hypotension has been reported to be a risk factor of falls (Allan et al. 2009). 
Those persons with active diagnosis of hypertension, and antihypertensive 
medication, may be robust persons having higher blood pressure, whereas 
those persons with lower blood pressure may be persons with more severe 
dementia having a "terminal decline" in their blood pressure (Benetos et al. 
2016). The fact that persons with two or more falls had lower blood pressure 
than persons with fewer falls supports this hypothesis. However, even frail 
patients have been suggested to benefit from antihypertensive drugs in a 
recent study among older hypertensive persons (Williamson et al. 2016). Their 
prognosis was improved by targeting systolic blood pressure to <120 mmHg 
without increasing falls (Williamson et al. 2016). However, their orthostatic 
hypotension was regularly monitored over the trial and their 
antihypertensives were accordingly modified (Supiano & Williamson 2017).  
Concerning interventions in reducing falls, a meta-analysis revealed 
multifactorial and exercise interventions to be most effective (Chang et al. 
2004). Reducing psychoactive medication and reducing the number of drugs 
can also be used as interventions among community-dwelling older people, as 
previously stated (AGS 2011). However, there is a scarcity of studies 
concerning forms of intervention to reduce falls among people with dementia. 
The results of recent meta-analyses have suggested that exercise may prevent 
falls among people with known dementia and cognitive impairment (Burton 
et al. 2015, Chan et al. 2015). In Study IV possible interactions between 
exercise intervention and FRDs were explored. Adding to the literature, 
exercise intervention was found to interact with psychotropic and 
antihypertensive drugs. Better circulation could be the mechanism in respect 
of antihypertensives, as exercise induces the calf muscles to work more 
effectively, which enhances blood flow to the heart and brain. Thus, the risk of 
orthostatic hypotension may be reduced. Better mobility and balance as a 
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result of exercise training serves as one explanation as regards both types of 
medication. There was no interaction effect between exercise and DAPs, 
although exercise intervention was associated with a decreased risk of falls 
among both DAP users and nonusers. A similar pattern was found among 
those with and without polypharmacy.  
The findings in this study indicate that among persons with dementia 
certain types of medication may increase the risk of falls. However, it is 
possible to completely compensate for this by means of exercise among users 
of psychotropic and antihypertensive drugs. Thus, exercise should be 
encouraged especially among dementia patients with hypertension. Those 
with dementia using psychotropic drugs should also be encouraged to exercise, 
although eliminating or reducing psychotropic drug use may be the primary 
aim in decreasing the risk of falls. Dementia patients with polypharmacy and 
those using DAPs should also be encouraged to exercise, although their risk of 
falls is not completely compensated by exercise. Thus, reducing polypharmacy 
and eliminating the use of DAPs should be the primary aim in these cases.  
6.5 STRENGTHS AND LIMITATIONS  
Helsinki Businessmen Study 
 
The Helsinki Businessmen Study has several strengths. It is one of the longest 
cohort studies. Characterization of the participants is thorough, and the 
response rates have been high. When investigating mechanisms regarding 
gender, race, and socioeconomic status, confounding is reduced because of the 
homogeneity of the participants. There are also some limitations in the 
Helsinki Businessmen Study. Generalization to other populations is limited 
because of the homogeneity and characteristics of the participants. The 
analyses are based solely on responses to postal questionnaires, with their 
inherent limitations. However, the educational status of the men was high, and 
thus the answers they gave may be more reliable than those provided by the 
general population (Schlademann et al. 2008). The number of falls was asked 
about and the participants responded solely on the basis of their memories of 
the previous year. On the other hand, fallers were defined as those having had 
at least one fall in the previous year. Thus, the outcome measure in Study I did 
not change according to the actual number of falls remembered within the 
previous year. The FI score was determined using 20 items, which is fewer 
than in several previous studies (Rockwood & Mitnitski 2007). However, no 
absolute threshold of items has been set and this study provides information 
on how low the number of items can be. The FI is a continuous score (Mitnitski 
et al. 2001), but in Study I it was defined in groups of not frail, prefrail and 
frail, with cut-off points of 0.08 for prefrail and 0.25 for frail, which have been 
used previously (Song et al. 2010). This categorization to not frail, prefrail and 
frail enabled comparison of FI and phenotype measures. Some of the groups 
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are relatively small because of the small sample size.  Small groups of 
participants are particularly evident in the Venn diagram presenting 
overlapping of the frail groups according to the three frailty measures. On the 
other hand, it is possible to observe differences in the frailty measures even 




The FINALEX study (a randomized controlled trial [RCT]) has several 
strengths. All participants had a diagnosis of AD based on the National 
Institute of Neurological and Communicative Disorders and Stroke and 
Alzheimer’s Disease and Related Disorders Association’s (NINCDS-ADRDA) 
criteria for diagnosis of probable AD (McKhann et al. 1984) and they were 
confirmed by a geriatrician. Intervention was highly coordinated and each 
training session was supervised by a physiotherapist. The intervention was 
also frequent (twice a week) and long-term (12 months). It was implemented 
by physiotherapists in primary care and did not increase the total costs of 
health and social services (Pitkala et al. 2013). The spouses kept fall diaries, 
which served to assess the falls. The fall diaries were continuously filled in by 
the spousal caregivers. A diary is a highly sensitive method in recording falls 
accurately (Hannan et al. 2010), giving reliability to the findings. The types of 
medication used and comorbidities were confirmed both from spousal 
caregivers and medical records. The baseline characteristics of the 
intervention and control groups were comparable and they presented similar 
features as seen in previous studies among persons with dementia (Allan et al. 
2009), giving reliability to the findings in this patient group. In Study II, 
definition of the stage of frailty was based on Fried criteria, which predict 
major endpoints such as disabilities and death (Fried et al. 2001). In Studies 
III and IV, the features behind falls were investigated in a prospective manner.  
The FINALEX study also has several limitations. All the participants were 
community-dwelling voluntary Caucasians living with their spousal caregivers 
in their homes. Generalization of the results to other populations should be 
approached with appropriate caution. The power of the study was decreased 
because of the small sample size. The study was not blinded. However, the 
study nurses collecting the data were not informed about the exact 
intervention and primary outcome measures and they were not researchers in 
the study. Moreover, the spousal caregivers were also not aware of the study 
hypothesis, and their evaluations were used to assess the FIM scores (Pollak 
et al. 1996) and falls of the participants. The control group received high-
quality community care, which probably decreased differences between the 
original intervention and control groups in Studies II and IV. Although the 
types of medication used at the end of the 12-month intervention period were 
not confirmed, the study intervention was not intended to change them. 
Studies II and IV involved subgroup analyses of the original RCT, and 
therefore the groups compared were not original randomized groups. In 
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addition, the intervention groups in these analyses contained both home-
based and group-based participants. However, the individual training time for 
both home-trainers and group-trainers was approximately one hour twice a 
week. In Study II, the participants could not be divided into the traditional 
three frailty-stage groups of robust, prefrail, and frail (Fried et al. 2001) 
because of the small number of participants. However, the inclusion criteria 
stated that all participants had to have at least one sign of frailty. Thus, it can 
be argued that all participants were either prefrail or frail persons. The 
intervention decreased the number of falls among intervention participants. 
Thus, in Study III, the total number of falls was lower than expected among 
persons with AD, and this may also have modified the features of the falls. 
However, the findings in Study III were adjusted for age, sex, and intervention 
as regards the risk factors of falls. The number of falls among the controls 
(Pitkala et al. 2013) was comparable to those in previous studies among 
persons with AD (Allan et al. 2009). The SPPB test was modified from the 
original test to give time and to better suit participants with dementia. It gave 
respective scores as in the original test and showed logically that performance 
in the SPPB test was lower among fallers than non-fallers. Thus, it can be 
argued that this modified test probably reflects well the points that each 
participant could have scored in the original SPPB.  
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7 CONCLUSIONS  
Both phenotype frailty measures and the FI can be used to identify frail people. 
Simple and easy-to-use frailty phenotype measures (e.g. Fried criteria) can be 
used to screen for those in need of exercise intervention, whereas the more 
laborious FI method could be used when assessing patients in detail in cases 
where more comprehensive geriatric intervention may be necessary.  
Intensive and long-term exercise intervention may benefit persons with 
AD, independently of their frailty stage, in respect of physical functioning and 
falls. In addition to previously known risk factors of falls among people with 
AD (a history of falls, older age, female gender, disability, use of psychotropic 
drugs, and decreased physical activity), this study revealed that use of 
anticholinergic drugs and opioids, and polypharmacy, lower systolic blood 
pressure, COPD, DM, and osteoarthritis are also risk factors of falls. In 
contrast to prior studies, the results of this study also suggested that 
hypertension and antihypertensive medication may be associated with a 
reduced risk of falls.  
When exploring the features of falls in detail among people with AD this 
study found that most falls occurred in the afternoon, and stumbling, 
dizziness, and weakness of the legs were the most common reasons for a fall. 
Those persons with an MMSE score around ten points fell most, every third 
fall led to injury, every seventh fall led to an emergency department visit, and 
4% of falls led to fracture. Exercise intervention has the potential to modify 
favorably the risk of falls among people with AD using antihypertensives, 
psychotropics and DAPs, and those with polypharmacy. Among those AD 
cases using antihypertensive or psychotropic drugs, exercise totally 
compensates for their risk of falls.  
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8 IMPLICATIONS FOR CLINICAL PRACTICE 
AND FUTURE RESEARCH  
Experts have not reached a consensus of opinion on the definition of frailty. 
However, it can be argued that different frailty measures could be used for 
different purposes. Simple physical frailty measures may provide a better tool 
to screen for those who could benefit from exercise intervention, whereas the 
FI can provide more detail but is a more laborious measure. Questionnaires 
may be used for screening by means of both phenotype measures and the FI. 
Frailty is one of the major health problems and needs to be carefully defined. 
Thus, more studies are needed to compare various frailty measures on the 
basis of both Fried criteria and the FI. In addition, questionnaire-based 
measures could be compared with clinically assessed measures in the same 
study population in respect of identifying prefrail and frail persons as well as 
predicting outcomes such as falls and mortality.  
Persons with AD should be encouraged to undertake exercise training 
regardless of their stage of frailty. More RCTs are needed in these patient 
groups to confirm the present findings.  
Poor physical functioning, certain diseases such as COPD and DM, and 
polypharmacy as well as certain types of drugs such as DAPs and psychotropics 
increase the risk of falls. Exercise should be encouraged in all cases to enhance 
physical functioning. Long-term use of DAPs and psychotropics, as well as 
polypharmacy, should be avoided. Excessive drug use should be reduced if 
possible. Further studies with more participants are needed to establish the 
associations between various drugs, diseases and physical conditions, and falls 
among people with dementia.  
Those persons in particular who need long-term use of DAPs or 
psychotropic drugs should be encouraged to undertake exercise training to 
reduce the risk of falls. Further studies including more participants are needed 
to confirm these findings. In addition, randomized controlled trials could also 
serve to investigate possible interactions between exercise and other drugs, as 
well as various diseases, on the risk of falls.  
Exercise intervention studies should be repeated in different settings and 
among persons of different cultures and origins to determine whether the 
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Appendix I. Helsinki Businessmen Study questionnaire in 2000 (in Finnish).  
 
JOHTAJATARKASTUKSISSA KÄYNEIDEN SEURANTATUTKIMUS VUONNA 2000  
 
Aluksi muutama kysymys nykyisistä elinoloistanne ja –tavoistanne:  
(ympyröikää vastauksenne kirjain tai kirjoittakaa vastaus viivalle)  
 
1. Oletteko vielä työelämässä  
a) kyllä  b) en. Olen eläkkeellä vuodesta _____  
2. Jos olette eläkkeellä, jäittekö alunperin  
a) vanhuuseläkkeelle  
b) varhennetulle vanhuseläkkeelle  
c) osa-aikaeläkkeelle  
d) työkyvyttömyyseläkkeelle  
e) työttömyyseläkkeelle  
f) minulla oli henkilökohtainen eläkesopimus  
3. Asutteko nykyisin  
a) kotona  
b) pysyvästi palvelutalossa  
c) pysyvästi vanhainkodissa  
d) pysyvästi hoivakodissa  
e) pysyvästi sairaalassa  
4. Mikä on nykyinen siviilisäätynne  
a) avioliitossa tai avoliitossa  
b) leski, _____ vuotta  
c) eronnut, _____ vuotta  
d) naimaton  
5. Tupakoitteko nykyisin?  
a) en ole koskaan tupakoinut  
b) lopetin vuonna _____  
c) kyllä tupakoin  
6. Montako vuotta olette elämänne aikana tupakoinut?  
_____ vuotta  
7. Vain nykyisin tupakoiville: miten paljon poltatte keskimäärin päivässä? 
a) savukkeita _____ kpl/pv  
b) piippua _____ piipullista/pv  
c) sikareja _____ kpl/pv  
d) pikkusikareja _____ kpl/pv  
8. Mikä on ollut keskimäärin alkoholin viikkokäyttönne viimeksi kuluneen vuoden aikana?  
a) oluttu _____ pullollista/viikko  
b) viiniä _____ lasillista/viikko  
c) väkeviä juomia _____ grogia (ravintola-annosta vastaava määrä/viikko)  
9. Harrastatteko liikuntaa säännöllisesti viikottain?  
a) en  
b) kyllä _____ tuntia/viikko  
10. Kuinka monta kertaa viikossa harrastatte hengästymistä ja hikoilua aiheuttavaa liikuntaa  
_____ kertaa viikossa  
11. Mikä on  
- nykyinen painonne _____ kg?  
- viimeisin verenpainelukemanne _____/_____  
- viimeisin kolesterolilukemanne (S-kol) _____ mmol/l  
- viimeisin verensokerilukemanne (B-gluk) _____ mmol/l  
 
Seuraavaksi muutama kysymys mahdollisista sairauksista ja lääkkeistä:  
 
12. Onko Teillä jokin pitkäaikainen (krooninen) sairaus, vika tai vamma?  
a) ei  




13. Jos Teillä on krooninen sairaus, vika tai vamma, heikentääkö se toimintakykyänne?  
a) ei   b) kyllä  
14. Kuinka monta viikkoa yhteensä olette viimeisen 5 vuoden aikana ollut sairaalahoidossa  
a) en yhtäkään  
b) _____ viikkoa  
 
Onko Teillä ollut tai on jotain seuraavista (ympyröikää vastauksenne)  
15. muistihäiriöitä    ei  kyllä, vuonna _____  
16. aivohalvaus tai aivoverenkiertohäiriö   ei  kyllä, vuonna _____  
17. kohonnut verenpaine    ei  kyllä, vuonna _____ 
18. sepelvaltimotauti    ei  kyllä, vuonna _____ 
19. sydämen vajaatoiminta   ei  kyllä, vuonna _____ 
20. krooninen keuhkosairaus   ei  kyllä, vuonna _____ 
21. alaraajojen verenkiertohäiriö   ei  kyllä, vuonna _____ 
22. diabetes (sokeritauti)    ei  kyllä, vuonna _____ 
23. syöpä     ei  kyllä, vuonna _____ 
24. tuki- ja liikuntaelinten sairaus   ei  kyllä, vuonna _____ 
25. mielenterveyden häiriö   ei  kyllä, vuonna _____ 
26. muu pitkäaikainen sairaus tai vamma, mikä  ei  kyllä, vuonna _____  
______________________________  
27. Käytättekö säännöllisesti jotain lääkettä (myös käsikauppalääkkeet, esim. aspiriini)  
a) ei  
b) kyllä ________________________________________  
28. Kirjoittakaa tähän säännöllinen lääkityksenne (viimeisen 6 kuukauden aikana käytetty): sekä 





Seuraavat kysmykset pyrkivät mittaamaan toimintakykyänne:  
 
29. Onko terveytenne yleisesti ottaen (ympyröikää yksi numero)  
1 erinomainen  
2 varsin hyvä  
3 hyvä  
4 tyydyttävä  
5 huono  
30. Jos vertaatte nykyistä terveydentilaanne vuoden takaiseen, onko terveytenne yleisesti 
ottaen (ympyröikää yksi numero)  
1 tällä hetkellä paljon parempi kuin vuosi sitten  
2 tällä hetkellä jonkin verran parempi kuin vuosi sitten  
3 suunnilleen samanlainen  
4 tällä hetkellä jonkin verran huonompi kuin vuosi sitten  
5 tällä hetkellä paljon huonompi kuin vuosi sitten  
 
Seuraavassa luetellaan erilaisia päivittäisiä toimintoja. Rajoittaako terveydentilanne nykyisiin 
suoriutumistanne seuraavista päivittäisistä toiminnoista? Jos rajoittaa, kuinka paljon? (ympyröikää 
yksi numero joka riviltä)  
   kyllä,     kyllä,     ei rajoita  
   rajoittaa     rajoittaa     lainkaan  
   paljon     hiukan  
31. Huomattavia ponnistuksia vaativat  
toiminnat (esimerkiksi juokseminen,  
raskaiden tavaroiden nostelu,  
rasittava urheilu) …………………………………..1………………………2……………………..3  
32. Kohtuullisia ponnistuksia vaativat  
toiminnat, kuten pöydän siirtäminen,  
imurointi, keilailu…………………………………..1………………………2……………………..3  
33. Ruokakassien nostaminen tai  
kantaminen…………………………………..……….1………………………2……………………..3  
34. Nouseminen portaita useita kerroksia……1………………………2……………………..3  
35. Nouseminen portaita yhden kerroksen….1………………………2……………………..3  
36. Vartalon taivuttaminen,  
polvistuminen, kumartuminen……….………1………………………2……………………..3  
37. Noin kahden kilometrin matkan kävely….1………………………2……………………..3  
38. Noin puolen kilometrin matkan kävely.. ..1………………………2……………………..3  
39. Noin 100 metrin matkan kävely……………..1………………………2……………………..3  
40. Kylpeminen tai pukeutuminen……….........1………………………2……………………..3  
 
  
Onko teillä viimeisen 4 viikon aikana ollut ruumiillisen terveydentilanne takia alla mainittuja ongelmia 
työssänne tai muissa tavanomaisissa päivittäisissä tehtävissänne? (ympyröikää yksi numero joka 
riviltä)  
Kyllä  ei  
41. Vähensitte työhön tai muihin tehtäviin käyttämäänne aikaa…………………1……………………..2  
42. Saitte aikaiseksi vähemmän kuin halusitte…………………………………………….1……………………..2  
43. Terveydentilanne asetti teille rajoituksia joissakin työ- tai  
muissa tehtävissä………………………………………………………………………………….1……………………..2  
44. Töistänne tai tehtävistänne suoriutuminen tuotti vaikeuksia  
(olette joutunut esim. ponnistelmeaan tavallista enemmän)………………. 1……………………..2  
 
Onko Teillä viimeisen 4 viikon aikana ollut tunne-elämään liittyvien vaikeuksien (esim. 
masentuneisuus tai ahdistuneisuus) takia alla mainittuja ongelmia työssänne tai muissa 
tavanomaisissa päivittäisissä tehtävissänne? (ympyröikää yksi numero joka riviltä)  
Kyllä  ei  
45. Vähensitte työhön tai muihin tehtäviin käyttämäänne aikaa…………………1……………………..2  
46. Saitte aikaiseksi vähemmän kuin halusitte…………………………………………….1……………………..2  
47. Ette suorittanut töitänne tai muita tehtäviänne yhtä  
huolellisesti kuin tavallisesti………………………………………………………………….1……………………..2  
 
48. Missä määrin ruumiillinen terveydentilanne tai tunne-elämän vaikeudet ovat viimeisen 4 
viikon aikana häirinneet tavanomaista (sosiaalista) toimintaanne perheen, ystävien, 
naapureiden tai muiden ihmisten parissa? (ympyröikää yksi numero)  
1 ei lainkaan  
2 hieman  
3 kohtalaisesti  
4 melko paljon  
5 erittäin paljon  
 
49. Kuinka voimakkaita ruumiillisia kipuja Teillä on ollut viimeisen 4 viikon aikana? (ympyröikää 
yksi numero)  
1 ei lainkaan  
2 hyvin lieviä  
3 lieviä  
4 kohtalaisia  
5 voimakkaita  
6 erittäin voimakkaita  
 
50. Kuinka paljon kipu on häirinnyt tavanomaista toimintaanne (kotona tai kodin ulkopuolella) 
viimeisen 4 viikon aikana? (ympyröikää yksi numero)  
1 ei lainkaan  
2 hieman  
3 kohtalaisesti  
4 melko paljon  

























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Appendix III. Mini-Nutritional Assessment (MNA, in Finnish) (Guigoz et al. 2002, 





Appendix IV. Short Physical Performance Battery (SPPB, in Finnish) 





Appendix V. Mini-Mental State Examination (MMSE, in Finnish) (Folstein et al. 1975).  
 
  
  
  
 
